# INFS 603 æ–‡ç»å›é¡§ - Week 1-3 é€²åº¦åŒ¯å ± ï¼ˆ20260124 updatedï¼‰

> **ç ”ç©¶å•é¡Œ**ï¼šç•¶å‰ UX è¨­è¨ˆå¯¦è¸å¦‚ä½•æœªèƒ½è€ƒæ…®è€å¹´äººçš„ AI ç´ é¤Šå’Œéš±ç§é¢¨éšªæ„ŸçŸ¥ï¼Œä»¥åŠé«˜å±¤åŸå‰‡ï¼ˆWHOã€NISTï¼‰èˆ‡ç•Œé¢å±¤å¯¦ç¾ä¹‹é–“çš„å·®è·

---

## ç›®éŒ„

1. [åŸ·è¡Œæ‘˜è¦](#ä¸€åŸ·è¡Œæ‘˜è¦)
2. [ç ”ç©¶ç›®æ¨™èˆ‡ä»»å‹™](#äºŒç ”ç©¶ç›®æ¨™èˆ‡ä»»å‹™)
3. [å››å¤§ä¸»é¡Œé ˜åŸŸèˆ‡ç¨®å­è«–æ–‡](#ä¸‰å››å¤§ä¸»é¡Œé ˜åŸŸèˆ‡ç¨®å­è«–æ–‡)
4. [æœç´¢çµæœåˆ†æ](#å››æœç´¢çµæœåˆ†æ)
5. [ç¾ç‹€åˆ†æèˆ‡æ”¹é€²ç­–ç•¥](#äº”ç¾ç‹€åˆ†æèˆ‡æ”¹é€²ç­–ç•¥)
6. [èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥](#å…­èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥)
7. [è¡Œå‹•è¨ˆåŠƒèˆ‡æ™‚é–“è¡¨](#ä¸ƒè¡Œå‹•è¨ˆåŠƒèˆ‡æ™‚é–“è¡¨)
8. [é™„éŒ„ï¼šæœç´¢å­—ä¸²èˆ‡å·¥å…·](#é™„éŒ„æœç´¢å­—ä¸²èˆ‡å·¥å…·)
9. Zotero pages

---

# ä¸€ã€åŸ·è¡Œæ‘˜è¦

## 1.1 Week 1-3 å®Œæˆæƒ…æ³ç¸½è¦½

| é …ç›®            | ç›®æ¨™                      | å¯¦éš›å®Œæˆï¼ˆRound 2 å¾Œï¼‰                                                             | ç‹€æ…‹             |
| --------------- | ------------------------- | ---------------------------------------------------------------------------------- | ---------------- |
| ç¨®å­è«–æ–‡è­˜åˆ¥    | 20-32 ç¯‡ï¼ˆæ¯ä¸»é¡Œ 5-8 ç¯‡ï¼‰ | 21 ç¯‡å·²è©•ä¼°ï¼ˆ6ç¯‡ Tier 1ï¼Œ4ç¯‡ Tier 2ï¼Œ1ç¯‡ Tier 3ï¼Œ7ç¯‡ Unacceptedï¼Œ3ç¯‡å¾…è©•ä¼°ï¼‰       | ğŸŸ¡ é€²è¡Œä¸­         |
| ä¸»é¡Œä¸€è¦†è“‹ç‡    | 100%                      | ~100% (8ç¯‡å·²æ”¶é›†ï¼Œ1 Tier 1, 3 Tier 2, 2 Tier 3)                                    | ğŸŸ¢ è‰¯å¥½           |
| ä¸»é¡ŒäºŒè¦†è“‹ç‡    | 100%                      | ~60% (3ç¯‡æ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼°) âœ… æ ¸å¿ƒç†è«–åŸºç¤å·²å®Œæˆï¼Œéœ€è£œå…… 1-2 ç¯‡ | ğŸŸ¢ æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ |
| ä¸»é¡Œä¸‰è¦†è“‹ç‡    | 100%                      | ~20% (1ç¯‡ Tier 2ï¼Œ5ç¯‡ Unaccepted)                                                  | ğŸŸ¡ éœ€è£œå……         |
| ä¸»é¡Œå››è¦†è“‹ç‡    | 100%                      | ~80% (6ç¯‡å·²æ”¶é›†ï¼Œ2 Tier 1, 4 ç°è‰²æ–‡ç») âœ…                                           | ğŸŸ¢ è‰¯å¥½           |
| Tier 1 æ–‡ç»æ¯”ä¾‹ | 40-50%                    | 29% (6ç¯‡)                                                                          | ğŸŸ¡ éœ€è£œå……         |
| æœç´¢è¨˜éŒ„æ–‡æª”    | å®Œæ•´è¨˜éŒ„                  | éƒ¨åˆ†è¨˜éŒ„                                                                           | ğŸŸ¡ éœ€è£œå……         |

## 1.2 é—œéµç™¼ç¾

### âœ… å®Œæˆæƒ…æ³ï¼ˆæ›´æ–°ï¼šä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å®Œæˆ Tier 1 è©•ä¼°ï¼Œä¸»é¡Œå››æ–°å¢ CIFARï¼‰
1. å»ºç«‹äº†ç³»çµ±æ€§çš„è«–æ–‡åˆ†é¡é«”ç³»ï¼ˆTier 1-3 + Unacceptedï¼‰
2. å®Œæˆ Round 2 è©•ä¼°ï¼Œæ˜ç¢ºåˆ†é¡ 21 ç¯‡æ–‡ç»ï¼š
   - **Tier 1**ï¼š6 ç¯‡ï¼ˆPeixoto 2025, Bhattacharya 2024, Brewer 2022 CHI EA, Gray 2018, Susser 2019, Brignull 2024ï¼‰âœ…
   - **Tier 2**ï¼š4 ç¯‡ï¼ˆAn 2025, Zubatiy 2023, Even 2022, Wildenbos 2018ï¼‰âœ…
   - **Tier 3**ï¼š1 ç¯‡ï¼ˆBrewer 2022ï¼‰
   - **Unaccepted**ï¼š7 ç¯‡ï¼ˆæ˜ç¢ºæ’é™¤ç†ç”±ï¼‰
   - **å¾…è©•ä¼°**ï¼š3 ç¯‡
3. æˆåŠŸæ”¶é›†ä¸»é¡Œä¸€ã€äºŒã€ä¸‰ã€å››çš„æ ¸å¿ƒæ–‡ç»ï¼š
   - ä¸»é¡Œä¸€ï¼š8 ç¯‡ï¼ˆå«æ–°å¢ï¼šHuang 2025, Du 2024, Brewer CHI EAï¼‰
   - **ä¸»é¡ŒäºŒï¼š3 ç¯‡æ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼°** âœ…ï¼ˆGray 2018, Susser 2019, Brignull 2024ï¼‰
   - **ä¸»é¡Œä¸‰ï¼š1 ç¯‡ Tier 2 æ–‡ç»å·²å®Œæˆè©•ä¼°** âœ…ï¼ˆWildenbos 2018 - MOLD-US æ¡†æ¶ï¼‰
   - ä¸»é¡Œå››ï¼š6 ç¯‡ï¼ˆPeixoto, Bhattacharya, NIST, WHO, CIFAR, Amiiï¼‰âœ…
4. æˆåŠŸè­˜åˆ¥ä¸¦ä¸‹è¼‰ CHIã€CSCWã€JMIR ç­‰é ‚æœƒ/æœŸåˆŠè«–æ–‡
5. å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zoteroï¼šNIST AI RMF (2023)ã€WHO Guidance (2021)ã€CIFAR (2023)ã€Amii (2023) ç°è‰²æ–‡ç» âœ…
6. **é‡è¦é€²å±•**ï¼šä¸»é¡ŒäºŒ 3 ç¯‡æ ¸å¿ƒæ–‡ç»å…¨éƒ¨å®Œæˆ Tier 1 è©•ä¼°ï¼Œä¸»é¡Œä¸‰ Wildenbos (2018) å®Œæˆ Tier 2 è©•ä¼°ï¼ŒTier 1 æ–‡ç»æ¯”ä¾‹ç‚º 29%ï¼ŒTier 2 æ–‡ç»æ¯”ä¾‹ç‚º 19%
7. **é‡è¦ç™¼ç¾**ï¼šä¸»é¡Œä¸‰å¤šæ•¸æ–‡ç»åœ¨ Round 2 è©•ä¼°ä¸­è¢«æ¨™è¨˜ç‚º Unacceptedï¼Œä½† Wildenbos (2018) çš„ MOLD-US æ¡†æ¶æä¾›çµæ§‹åŒ–æ–¹æ³•è­˜åˆ¥è€å¹´å¯ç”¨æ€§éšœç¤™ï¼Œå¯æ‰¹åˆ¤æ€§æ“´å±•ä»¥æ¶µè“‹å°è©±ä»£ç†æƒ…å¢ƒ

### âœ… å·²å®Œæˆé …ç›®ï¼ˆæ›´æ–°ï¼šä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å®Œæˆ Tier 1 è©•ä¼°ï¼‰

1. âœ… **ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ** â€” Gray et al. (2018)ã€Susser et al. (2019) å’Œ Brignull (2024) å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼° âœ…
   - ä¸‰ç¯‡æ ¸å¿ƒæ–‡ç»å·²æˆåŠŸå®šä½ã€ä¸‹è¼‰ã€å°å…¥ Zotero ä¸¦å®Œæˆä¸‰ç¶­åº¦è¦†è“‹åˆ†æ
   - æ ¸å¿ƒç†è«–åŸºç¤å·²å»ºç«‹ï¼Œè¦†è“‹ç‡ 60%ï¼ˆ3/5 ç¯‡ï¼‰
2. âœ… **ä¸»é¡Œå››ç°è‰²æ–‡ç»æ›´æ–°** â€” CIFAR (2023) å’Œ Amii (2023) å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero âœ…
3. âœ… **ä¸»é¡Œä¸‰ Wildenbos è©•ä¼°å®Œæˆ** â€” Wildenbos et al. (2018) å·²å®Œæˆ Tier 2 è©•ä¼° âœ…

### âš ï¸ ä»éœ€æ”¹é€²çš„é …ç›®

1. **ä¸»é¡ŒäºŒè£œå……æœç´¢** ğŸŸ ï¼ˆé«˜å„ªå…ˆç´šï¼‰â€” ç‚ºé”åˆ° 80-100% è¦†è“‹ç‡ï¼Œéœ€è£œå…… 1-2 ç¯‡æ–‡ç»ï¼ˆå¦‚ Gull 2025ã€FAccT æœƒè­°è«–æ–‡ï¼‰
   - **å„ªå…ˆç´šé‡æ–°è©•ä¼°**ï¼šé›–ç„¶æ ¸å¿ƒæ–‡ç»ï¼ˆGray, Susser, Brignullï¼‰å·²å®Œæˆï¼Œä½†ç ”ç©¶è¨ˆåŠƒæ›¸å¼·èª¿ã€Œæš—é»‘æ¨¡å¼æ–‡ç»æ˜¯å»ºç«‹æ‰¹åˆ¤æ€§åˆ†ææ¡†æ¶çš„ç†è«–åŸºç¤ã€ï¼Œä¸”ã€Œç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ˜¯è¨­è¨ˆå¯¦è¸çš„ç¼ºå£ã€ã€‚å› æ­¤ï¼Œè£œå……æœç´¢æ‡‰åˆ—ç‚º**é«˜å„ªå…ˆç´š**è€Œéã€Œéç·Šæ€¥ã€ã€‚
   - **å…·é«”è¡Œå‹•**ï¼š
     - æª¢æŸ¥ Gull (2025) - é€šé McGill åœ–æ›¸é¤¨ç¢ºèªé›»å­æ›¸è¨ªå•æ¬Šé™ï¼ˆæœ¬é€±å…§å®Œæˆï¼‰
     - åŸ·è¡Œ FAccT æœƒè­°è«–æ–‡è£œå……æœç´¢ï¼Œç›®æ¨™æ‰¾åˆ° 1-2 ç¯‡ç›¸é—œæ–‡ç»ï¼ˆWeek 3 åˆï¼‰
2. **ä¸»é¡Œä¸‰éœ€é‡æ–°è©•ä¼°** ğŸ”´ï¼ˆæœ€å„ªå…ˆï¼‰â€” Round 2 è©•ä¼°é¡¯ç¤ºä¸»é¡Œä¸‰çš„ 6 ç¯‡æ–‡ç»ä¸­æœ‰ 5 ç¯‡è¢«æ¨™è¨˜ç‚º Unacceptedï¼Œå› ç‚ºå®ƒå€‘æœªç›´æ¥é€£çµå°è©±å¼ AI çš„ç•Œé¢è¨­è¨ˆæˆ–ä¸‰ç¶­åº¦åˆ†ææ¡†æ¶ã€‚éœ€è¦é‡æ–°æœç´¢æ›´ç¬¦åˆç ”ç©¶å•é¡Œçš„æ–‡ç»ã€‚
   - **é—œéµè®ŠåŒ–èªªæ˜**ï¼šEllis et al. (2025) å¾åŸè¨ˆåŠƒçš„ã€Œæ ¸å¿ƒæ–‡ç»ã€è½‰ç‚ºã€ŒUnacceptedã€ï¼Œåæ˜ äº†è©•ä¼°æ¨™æº–çš„åš´æ ¼åŒ–ã€‚ç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ˜¯ã€Œ**ç•Œé¢è¨­è¨ˆå¯¦è¸çš„ç¼ºå£**ã€ï¼Œè€Œéåƒ…æ˜¯ã€Œæ„ŸçŸ¥å•é¡Œçš„å­˜åœ¨ã€ã€‚
   - **æ›¿ä»£æ–¹æ¡ˆ**ï¼šéœ€è¦å°‹æ‰¾èšç„¦æ–¼ã€Œç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿è€å¹´äººéš±ç§é¢¨éšªæ„ŸçŸ¥ã€çš„æ–‡ç»ï¼Œæˆ–ã€Œè¨­è¨ˆå¹²é å¦‚ä½•ç³¾æ­£æ„ŸçŸ¥åå·®ã€çš„ç ”ç©¶ã€‚
3. **Tier 1 æ–‡ç»æ¯”ä¾‹ä»éœ€æå‡** ğŸŸ ï¼ˆé«˜å„ªå…ˆç´šï¼‰â€” ç›®å‰æœ‰ 6 ç¯‡ Tier 1 æ–‡ç»ï¼ˆ29%ï¼‰ï¼Œç†æƒ³æ‡‰é”åˆ° 40-50%
   - **ç›®æ¨™è¨ˆç®—**ï¼šå‡è¨­æœ€çµ‚ç¨®å­è«–æ–‡ç¸½æ•¸ç‚º 24 ç¯‡ï¼Œè¦é”åˆ° 40% éœ€è¦ç´„ **10 ç¯‡ Tier 1 æ–‡ç»**ï¼ˆç›®å‰ 6 ç¯‡ï¼Œéœ€è£œå…… 4 ç¯‡ï¼‰
   - **å„ä¸»é¡Œè£œå……ç›®æ¨™**ï¼š
     - ä¸»é¡Œä¸€ï¼šå¾ 1 ç¯‡æå‡è‡³ 2-3 ç¯‡ï¼ˆè£œå…… 1-2 ç¯‡ï¼‰
     - ä¸»é¡ŒäºŒï¼šç¶­æŒç¾æœ‰ 3 ç¯‡ï¼ˆå·²é”æ¨™ï¼‰
     - ä¸»é¡Œä¸‰ï¼šå¾ 0 ç¯‡æå‡è‡³ 2 ç¯‡ï¼ˆè£œå…… 2 ç¯‡ï¼Œ**æœ€å„ªå…ˆ**ï¼‰
     - ä¸»é¡Œå››ï¼šç¶­æŒç¾æœ‰ 2 ç¯‡ï¼ˆå·²é”æ¨™ï¼‰
   - **å„ªå…ˆé †åº**ï¼šä¸»é¡Œä¸‰ > ä¸»é¡Œä¸€ > ä¸»é¡ŒäºŒè£œå……
4. **æœç´¢è¨˜éŒ„éœ€å®Œå–„** ğŸŸ¡ï¼ˆä¸­å„ªå…ˆç´šï¼‰â€” è£œå……æœç´¢éç¨‹çš„è©³ç´°è¨˜éŒ„
   - **ç¼ºå¤±å…§å®¹**ï¼šRound 2 è£œå……æœç´¢çš„éç¨‹ã€ä½œè€…åæœç´¢çš„éç¨‹ã€ç°è‰²æ–‡ç»ç²å–éç¨‹
   - **è£œæ•‘è¨ˆåŠƒ**ï¼šå»ºç«‹æœç´¢è¨˜éŒ„æ¨¡æ¿ï¼ˆè¦‹ä¸‹æ–¹ï¼‰ï¼Œå›æº¯è¨˜éŒ„å·²å®Œæˆæœç´¢ï¼Œæœªä¾†æœç´¢å³æ™‚è¨˜éŒ„

## 1.3 ä¸‹ä¸€æ­¥å„ªå…ˆè¡Œå‹•

| å„ªå…ˆç´š       | è¡Œå‹•                                                                              | æˆªæ­¢æ™‚é–“  |
| ------------ | --------------------------------------------------------------------------------- | --------- |
| âœ… **å·²å®Œæˆ** | å®šä½å’Œä¸‹è¼‰æš—é»‘æ¨¡å¼æ ¸å¿ƒæ–‡ç»ï¼ˆGray et al. 2018, Susser et al. 2019, Brignull 2024ï¼‰ | âœ… å·²å®Œæˆ  |
| âœ… **å·²å®Œæˆ** | å®Œæˆä¸»é¡ŒäºŒå·²æ”¶é›†æ–‡ç»çš„ Tier è©•ä¼°å’Œåˆ†é¡ï¼ˆå…¨éƒ¨è©•ç‚º Tier 1ï¼‰                         | âœ… å·²å®Œæˆ  |
| âœ… **å·²å®Œæˆ** | ä¸‹è¼‰ CIFAR (2023) ç°è‰²æ–‡ç»                                                        | âœ… å·²å®Œæˆ  |
| ğŸ”´ **æœ€é«˜**   | é‡æ–°æœç´¢ä¸»é¡Œä¸‰æ–‡ç»ï¼Œå°‹æ‰¾ç›´æ¥é€£çµå°è©±å¼ AI ç•Œé¢è¨­è¨ˆçš„æ–‡ç»                          | Week 3 åˆ |
| ğŸŸ  **é«˜**     | ä¸»é¡ŒäºŒè£œå……æœç´¢ï¼ˆGull 2025, FAccT æœƒè­°è«–æ–‡ç­‰ï¼‰â€” æ ¸å¿ƒç†è«–åŸºç¤ï¼Œéœ€è£œå…… 1-2 ç¯‡        | Week 3 åˆ |
| ğŸŸ  **é«˜**     | è£œå…… Tier 1 æ–‡ç»ï¼Œæé«˜ä¸‰ç¶­åº¦è¦†è“‹æ–‡ç»æ¯”ä¾‹è‡³ 40-50%ï¼ˆç›®æ¨™ï¼š10 ç¯‡ï¼Œéœ€è£œå…… 4 ç¯‡ï¼‰     | Week 3 ä¸­ |
| ğŸŸ¡ **ä¸­**     | å®Œæˆå¾…è©•ä¼°æ–‡ç»çš„åˆ†é¡ï¼ˆHuang 2025 ç­‰ï¼‰â€” ä½¿ç”¨ Round 2 è©•ä¼°æ¨™æº–                      | Week 3 åˆ |
| ğŸŸ¡ **ä¸­**     | å»ºç«‹æœç´¢è¨˜éŒ„æ¨¡æ¿ä¸¦è£œå……ç¼ºå¤±è¨˜éŒ„ï¼ˆå›æº¯ Round 2 æœç´¢éç¨‹ï¼‰                           | Week 3 ä¸­ |
| âœ… **å·²å®Œæˆ** | ä¸‹è¼‰ Amii ç°è‰²æ–‡ç» âœ… å·²å®šä½ä¸¦ä¸‹è¼‰ PDFï¼ŒZotero å·²æ›´æ–°                              | âœ… å·²å®Œæˆ  |

---

# äºŒã€ç ”ç©¶ç›®æ¨™èˆ‡ä»»å‹™

## 2.1 Week 1-3 é å®šä»»å‹™

æ ¹æ“š INFS 603 èª²ç¨‹è¦æ±‚ï¼Œæœ¬éšæ®µéœ€å®Œæˆï¼š

1. **é–±è®€èƒŒæ™¯æ–‡ç»** â€” å»ºç«‹ AI å¥åº·æœå‹™é ˜åŸŸçš„åŸºç¤çŸ¥è­˜
2. **å­¸ç¿’é—œéµæ¦‚å¿µ** â€” ç†è§£ HCI å’Œ UX åœ¨é†«ç™‚ä¿å¥ä¸­çš„æ‡‰ç”¨
3. **è­˜åˆ¥ç¨®å­è«–æ–‡** â€” æ¯å€‹ä¸»é¡Œé ˜åŸŸé¸æ“‡ 5-8 ç¯‡æ ¸å¿ƒè«–æ–‡
4. **å¼•æ–‡è¿½è¹¤æº–å‚™** â€” ç‚º backward/forward chaining å»ºç«‹èµ·é»
5. **ç¶­è­·æœç´¢è¨˜éŒ„** â€” ç¢ºä¿ç ”ç©¶éç¨‹çš„é€æ˜æ€§å’Œå¯é‡è¤‡æ€§
6. **é–‹ç™¼æ¦‚å¿µåœ–** â€” æ•´ç†ä¸»é¡Œé–“çš„é—œè¯

## 2.2 ä»»å‹™åŸ·è¡Œé‚è¼¯

```
Week 1-2ï¼šåŸ·è¡Œåˆæ­¥æœç´¢ â†’ è­˜åˆ¥å€™é¸è«–æ–‡ â†’ åˆæ­¥åˆ†é¡
    â†“
Week 2 æœ«ï¼šæª¢è¨æœç´¢çµæœ â†’ è¨ºæ–·å•é¡Œ â†’ èª¿æ•´ç­–ç•¥
    â†“
Week 3ï¼šè£œå……æœç´¢ â†’ ç¢ºèªç¨®å­è«–æ–‡ â†’ æº–å‚™å¼•æ–‡è¿½è¹¤
```

**ç‚ºä»€éº¼é€™æ¨£å®‰æ’**ï¼š
- å…ˆå¯¬æ³›æœç´¢å»ºç«‹æ–‡ç»åŸºç¤ï¼Œå†æ ¹æ“šçµæœèª¿æ•´ç­–ç•¥
- é ç•™æ™‚é–“é€²è¡Œä¸­æœŸæª¢è¨ï¼Œé¿å…æ–¹å‘åå·®
- ç¢ºä¿é€²å…¥ Week 4 å‰æœ‰è¶³å¤ çš„ç¨®å­è«–æ–‡é€²è¡Œæ·±åº¦è¿½è¹¤

---

# ä¸‰ã€å››å¤§ä¸»é¡Œé ˜åŸŸèˆ‡ç¨®å­è«–æ–‡

## 3.1 ä¸»é¡Œæ¦‚è¦½

ç ”ç©¶å•é¡Œæ¶‰åŠå››å€‹äº¤å‰å±¤æ¬¡ï¼Œéœ€è¦å¾ä¸åŒè§’åº¦å»ºç«‹æ–‡ç»åŸºç¤ï¼š

| ä¸»é¡Œ       | ç ”ç©¶ç„¦é»                             | èˆ‡ç ”ç©¶å•é¡Œçš„é—œè¯             |
| ---------- | ------------------------------------ | ---------------------------- |
| **ä¸»é¡Œä¸€** | HCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰    | ç†è§£è€å¹´äººå¦‚ä½•èˆ‡ AI ç³»çµ±äº’å‹• |
| **ä¸»é¡ŒäºŒ** | AI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±                    | è­˜åˆ¥è¨­è¨ˆå¯¦è¸ä¸­çš„é¢¨éšªèˆ‡ç¼ºå£   |
| **ä¸»é¡Œä¸‰** | æ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº | äº†è§£å¥åº·ç§‘æŠ€å°è€å¹´äººçš„æŒ‘æˆ°   |
| **ä¸»é¡Œå››** | æ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI                | å»ºç«‹é«˜å±¤åŸå‰‡çš„åƒç…§åŸºæº–       |

## 3.2 ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰

### ç ”ç©¶ç›®çš„
ç†è§£è€å¹´äººèˆ‡å°è©±å¼ AI ç³»çµ±çš„äº’å‹•æ¨¡å¼ã€ä¿¡ä»»å»ºç«‹éç¨‹ï¼Œä»¥åŠç¾æœ‰è¨­è¨ˆå¦‚ä½•ï¼ˆæœªèƒ½ï¼‰æ”¯æŒé€™ä¸€ç¾¤é«”ã€‚

### ç¨®å­è«–æ–‡æ¸…å–®

| è«–æ–‡                         | ä¾†æº               | ç‹€æ…‹     | Tier åˆ†é¡        | é¸æ“‡ç†ç”±                                                                                                       |
| ---------------------------- | ------------------ | -------- | ---------------- | -------------------------------------------------------------------------------------------------------------- |
| Zubatiy et al. (2023)        | PACM HCI (CSCW2)   | âœ… å·²æ”¶é›† | **Tier 2**       | æ¢è¨å°è©±ä»£ç†åœ¨ç…§è­·ç¶²çµ¡ä¸­çš„é™åˆ¶ï¼›ä¸‰ç¶­åº¦ï¼šUsability, Transparency (indirect), Persuasive Design (gap)            |
| Brewer et al. (2022)         | ACM TiiS           | âœ… å·²æ”¶é›† | **Tier 3**       | è€å¹´äººèªéŸ³åŠ©ç†å¥åº·ä¿¡æ¯å°‹æ±‚çš„å¯¦è­‰ç ”ç©¶ï¼›æä¾›å¯¦è­‰æ•¸æ“šé¡¯ç¤ºéåº¦ä¿¡ä»»æˆ–èª¤è§£                                           |
| An et al. (2025)             | arXiv              | âœ… å·²æ”¶é›† | **Tier 2**       | è€å¹´äººå¥åº·å°è©±ä»£ç†ç³»çµ±æ€§æ–‡ç»å›é¡§ï¼›è¦†è“‹ Usabilityï¼ŒTransparency å’Œ Persuasive Design éœ€ç¢ºèª                     |
| Even et al. (2022)           | Z Gerontol Geriatr | âœ… å·²æ”¶é›† | **Tier 2**       | å°è©±ä»£ç†å°è€å¹´äººçš„ç›Šè™•èˆ‡æŒ‘æˆ°ï¼›è¦†è“‹ Usability, Transparency (implicit), Persuasive Design (gap)                 |
| Martin-Hammond et al. (2019) | JMIR Aging         | âœ… å·²æ”¶é›† | âŒ **Unaccepted** | åƒ…æ¢ç´¢æ…‹åº¦ä¿¡å¿µï¼Œæœªåˆ†æç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿é€™äº›ä¿¡å¿µ                                                                 |
| Brewer (2022) CHI EA         | CHI EA             | âœ… å·²æ”¶é›† | **Tier 1**       | "If Alexa knew the state I was in" - ä¸‰ç¶­åº¦è¦†è“‹ï¼šPersuasive Design (anthropomorphism), Usability, Transparency |
| Huang et al. (2025)          | CHI 2025           | âœ… å·²æ”¶é›† | â³ å¾…è©•ä¼°         | è¨­è¨ˆå°è©±å¼ AI çš„ç³»çµ±æ€§å›é¡§                                                                                     |
| Du et al. (2024)             | Chinese CHI 2024   | âœ… å·²æ”¶é›† | **Tier 3**       | å¢å¼·è€å¹´äººç”Ÿæ´»çš„å°è©±ä»£ç†ç³»çµ±æ€§å›é¡§                                                                             |

### ç•¶å‰è¦†è“‹ç‡ï¼š~100% ğŸŸ¢ï¼ˆ8ç¯‡å·²æ”¶é›†ï¼Œå« 1 ç¯‡ Tier 1, 3 ç¯‡ Tier 2, 2 ç¯‡ Tier 3, 1 ç¯‡ Unaccepted, 1 ç¯‡å¾…è©•ä¼°ï¼‰

### è£œå……æœç´¢å»ºè­°
- æœç´¢ ASSETS 2020-2025 æœƒè­°è«–æ–‡
- è¿½è¹¤æ ¸å¿ƒä½œè€…ï¼ˆElizabeth Mynatt, Robin Brewer, Anne Marie Piperï¼‰

---

## 3.3 ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±

### ç ”ç©¶ç›®çš„
å»ºç«‹æš—é»‘æ¨¡å¼å’Œæ“ç¸±è¨­è¨ˆçš„ç†è«–åŸºç¤ï¼Œç”¨æ–¼åˆ†æå¥åº· AI ç³»çµ±ä¸­çš„è¨­è¨ˆé¢¨éšªã€‚

### ç¨®å­è«–æ–‡æ¸…å–®

| è«–æ–‡                     | ä¾†æº                   | ç‹€æ…‹         | Tier åˆ†é¡    | é¸æ“‡ç†ç”±                                                                                           |
| ------------------------ | ---------------------- | ------------ | ------------ | -------------------------------------------------------------------------------------------------- |
| **Gray et al. (2018)**   | CHI 2018               | âœ… **å·²æ”¶é›†** | âœ… **Tier 1** | æš—é»‘æ¨¡å¼çš„å¥ åŸºæ€§ç ”ç©¶ï¼›ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern identification, trust/exploitation, design/analysis |
| **Susser et al. (2019)** | Internet Policy Review | âœ… **å·²æ”¶é›†** | âœ… **Tier 1** | æŠ€è¡“æ“ç¸±çš„ç†è«–æ¡†æ¶ï¼›ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/autonomy, trust/manipulation, design/ethics                   |
| **Brignull (2023/2024)** | Book (Testimonium Ltd) | âœ… **å·²æ”¶é›†** | âœ… **Tier 1** | æ¬ºé¨™æ€§è¨­è¨ˆçš„å¯¦è¸åˆ†é¡ï¼›ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern recognition, trust/deception, design/practice       |
| Gull (2025)              | Springer               | â³ å¾…ç²å–     | â³ å¾…è©•ä¼°     | ä»£ç†è¨­è¨ˆæ¨¡å¼                                                                                       |
| FAccT æœƒè­°è«–æ–‡           | ACM FAccT              | âŒ å¾…æœç´¢     | â³ å¾…è©•ä¼°     | å…¬å¹³æ€§èˆ‡é€æ˜åº¦                                                                                     |

### ç•¶å‰è¦†è“‹ç‡ï¼š~60% ğŸŸ¢ **æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ**ï¼ˆ3ç¯‡æ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼° âœ…ï¼‰

**å®Œæˆç‹€æ…‹**ï¼š
- âœ… 3 ç¯‡æ ¸å¿ƒæ–‡ç»ï¼ˆGray, Susser, Brignullï¼‰å·²æˆåŠŸå®šä½ã€ä¸‹è¼‰ã€å°å…¥ Zotero ä¸¦å®Œæˆ Tier 1 è©•ä¼°
- âœ… æ ¸å¿ƒç†è«–åŸºç¤å·²å»ºç«‹ï¼Œä¸‰ç¶­åº¦è¦†è“‹åˆ†æå·²å®Œæˆ
- ğŸŸ¡ ç‚ºé”åˆ° 80-100% ç›®æ¨™ï¼Œä»éœ€è£œå…… 1-2 ç¯‡æ–‡ç»ï¼ˆéç·Šæ€¥ï¼‰

### ç¾ç‹€åˆ†æï¼ˆæ›´æ–°ï¼šæ ¸å¿ƒæ–‡ç»å·²æ”¶é›†ï¼‰

ç ”ç©¶è¨ˆåŠƒæ›¸çš„åˆæ­¥æ›¸ç›®ä¸­å·²åˆ—å‡º Gray et al. (2018)ã€Susser et al. (2019) å’Œ Brignull (2024) ä½œç‚ºæ ¸å¿ƒæ–‡ç»ã€‚âœ… **å·²å®Œæˆ**ï¼šé€šéé‡å°æ€§çš„ä½œè€…åæœç´¢å’Œç›´æ¥è¨ªå•æœŸåˆŠç¶²ç«™ï¼Œå·²æˆåŠŸå®šä½ä¸¦ä¸‹è¼‰ä»¥ä¸‹æ ¸å¿ƒæ–‡ç»ï¼š

- âœ… **Gray et al. (2018)** - CHI 2018 - "The Dark (Patterns) Side of UX Design"
  - DOI: https://doi.org/10.1145/3173574.3174108
  - å·²ä¸‹è¼‰ PDF ä¸¦æ›´æ–°è‡³ Zotero
  
- âœ… **Susser et al. (2019)** - Internet Policy Review - "Technology, Autonomy, and Manipulation"
  - DOI: https://doi.org/10.14763/2019.2.1410
  - å·²ä¸‹è¼‰ PDF ä¸¦æ›´æ–°è‡³ Zotero

- âœ… **Brignull (2023/2024)** - "Deceptive Patterns: exposing the tricks tech companies use to control you"
  - Publisher: Testimonium Ltd (Eastbourne, England)
  - Edition: First edition: 2 January 2024
  - ISBN: 978-1-7394544-1-8, 978-1-7394544-0-1, 978-1-7394544-2-5
  - å·²ä»¥ epub æ ¼å¼æ”¶éŒ„ä¸¦æ›´æ–°è‡³ Zotero

**å®Œæˆç‹€æ…‹**ï¼šâœ… **æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ**
- âœ… å·²å®šä½ã€ä¸‹è¼‰ä¸¦å°å…¥ Zoteroï¼šGray et al. (2018), Susser et al. (2019), Brignull (2023/2024)
- âœ… å·²å®Œæˆ Tier è©•ä¼°å’Œåˆ†é¡ï¼šå…¨éƒ¨è©•ç‚º **Tier 1**
- âœ… ä¸‰ç¶­åº¦è¦†è“‹åˆ†æå·²å®Œæˆ

**å¾…è£œå……**ï¼ˆéç·Šæ€¥ï¼‰ï¼š
- â³ æª¢æŸ¥ Gull (2025) - é€šé McGill åœ–æ›¸é¤¨ç¢ºèªé›»å­æ›¸è¨ªå•æ¬Šé™
- â³ æœç´¢ FAccT æœƒè­°è«–æ–‡ - è£œå…… 1-2 ç¯‡æš—é»‘æ¨¡å¼ç›¸é—œæ–‡ç»ï¼ˆç›®æ¨™ï¼šå¾ 60% â†’ 80-100%ï¼‰

### ç‚ºä»€éº¼é€™å€‹ä¸»é¡Œå„ªå…ˆ

- ç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ˜¯ã€Œè¨­è¨ˆå¯¦è¸çš„ç¼ºå£ã€
- æš—é»‘æ¨¡å¼æ–‡ç»æ˜¯å»ºç«‹æ‰¹åˆ¤æ€§åˆ†ææ¡†æ¶çš„ç†è«–åŸºç¤
- Gray et al. (2018) æ˜¯è©²é ˜åŸŸè¢«å¼•ç”¨æœ€å¤šçš„è«–æ–‡ä¹‹ä¸€

### ä¸‹ä¸€æ­¥è¡Œå‹•ï¼ˆæ›´æ–°ï¼šæ ¸å¿ƒæ–‡ç»å·²æ”¶é›†ï¼‰

1. âœ… **å·²å®Œæˆ**ï¼šå®šä½ Gray et al. (2018) - å·²é€šé ACM Digital Library ä¸‹è¼‰
2. âœ… **å·²å®Œæˆ**ï¼šå®šä½ Susser et al. (2019) - å·²é€šé Internet Policy Review ç¶²ç«™ä¸‹è¼‰
3. âœ… **å·²å®Œæˆ**ï¼šç¢ºèª Brignull (2023/2024) - å·²ç¢ºèªç‚ºæ›¸ç±ï¼ˆTestimonium Ltdï¼‰ï¼Œå·²ä»¥ epub æ ¼å¼æ”¶éŒ„
4. âœ… **å·²å®Œæˆ**ï¼šå®Œæˆå·²æ”¶é›†æ–‡ç»çš„ Tier è©•ä¼°å’Œåˆ†é¡ï¼ˆGray 2018, Susser 2019, Brignull 2024ï¼‰â€” å…¨éƒ¨è©•ç‚º **Tier 1**
5. â³ **å¾…å®Œæˆ**ï¼šæª¢æŸ¥ Gull (2025) - é€šé McGill åœ–æ›¸é¤¨ç¢ºèªé›»å­æ›¸è¨ªå•æ¬Šé™

---

## 3.4 ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº

### ç ”ç©¶ç›®çš„
äº†è§£è€å¹´äººä½¿ç”¨æ•¸å­—å¥åº·å·¥å…·çš„å¯ç”¨æ€§æŒ‘æˆ°ã€éš±ç§æ„ŸçŸ¥ï¼Œä»¥åŠç¾æœ‰è¨­è¨ˆæ¡†æ¶ã€‚

### ç¨®å­è«–æ–‡æ¸…å–®

| è«–æ–‡                           | ä¾†æº             | ç‹€æ…‹               | é¸æ“‡ç†ç”±                                 |
| ------------------------------ | ---------------- | ------------------ | ---------------------------------------- |
| **Ellis et al. (2025)**        | J Am Geriatr Soc | âœ… å·²æ”¶é›†           | Halo effect èˆ‡éš±ç§æ„ŸçŸ¥â€”â€”ç›´æ¥æ”¯æŒç ”ç©¶å•é¡Œ |
| **Wildenbos et al. (2018)**    | Int J Med Inform | âœ… å·²æ”¶é›†           | MOLD-US æ¡†æ¶â€”â€”è€å¹´äººç§»å‹•å¥åº·å¯ç”¨æ€§       |
| Sakaguchi-Tang et al. (2017)   | JMIR Med Inform  | âœ… å·²æ”¶é›†           | è€å¹´äººæ‚£è€…é–€æˆ¶ç³»çµ±æ€§ç¶œè¿°                 |
| Kidman et al. (2024)           | JMIR             | âœ… å·²æ”¶é›†           | å¥åº·æ‡‰ç”¨æ”¾æ£„è¡Œç‚ºï¼ˆ22å€‹åŸå› ï¼Œ6å¤§é¡åˆ¥ï¼‰    |
| Ma et al. (2023)               | Ageing Res Rev   | âœ… å·²æ”¶é›†ï¼ŒèƒŒæ™¯åƒè€ƒ | AI åœ¨è€å¹´é†«ç™‚ä¿å¥çš„ç¯„åœå¯©æŸ¥              |
| Patient Portal Barriers (2024) | JMIR             | âœ… å·²æ”¶é›†           | æ‚£è€…é–€æˆ¶éšœç¤™èˆ‡ç¾¤é«”å·®ç•°                   |

### ç•¶å‰è¦†è“‹ç‡ï¼š~85% ğŸŸ¢ï¼ˆ6ç¯‡å·²æ”¶é›†ï¼‰

### é‡è¦æ–‡ç»èªªæ˜

**Ellis et al. (2025) - "The Halo Effect"**ï¼šå·²æˆåŠŸæ”¶é›†ã€‚æ­¤æ–‡æä¾›è€å¹´äººå› ä¿¡ä»»é†«ç™‚æ©Ÿæ§‹è€Œä½ä¼°éš±ç§é¢¨éšªçš„å¯¦è­‰è­‰æ“šï¼ˆhalo effectï¼‰ï¼Œç›´æ¥æ”¯æŒç ”ç©¶å•é¡Œä¸­ã€ŒUX è¨­è¨ˆå¯¦è¸æœªèƒ½è€ƒæ…®è€å¹´äººéš±ç§é¢¨éšªæ„ŸçŸ¥ã€çš„æ ¸å¿ƒè«–é»ã€‚

**Wildenbos et al. (2018) - MOLD-US æ¡†æ¶**ï¼šå·²æˆåŠŸæ”¶é›†ã€‚æ­¤æ¡†æ¶ç³»çµ±æ€§åœ°è­˜åˆ¥äº†å½±éŸ¿è€å¹´äººç§»å‹•å¥åº·å¯ç”¨æ€§çš„éšœç¤™å› ç´ ï¼Œç‚ºåˆ†æè¨­è¨ˆå¯¦è¸ç¼ºå£æä¾›äº†çµæ§‹åŒ–å·¥å…·ã€‚

---

## 3.5 ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI

### ç ”ç©¶ç›®çš„
å»ºç«‹é«˜å±¤åŸå‰‡ï¼ˆWHOã€NISTï¼‰çš„åƒç…§åŸºæº–ï¼Œç”¨æ–¼åˆ†æã€ŒåŸå‰‡èˆ‡å¯¦è¸çš„å·®è·ã€ã€‚

### ç¨®å­è«–æ–‡æ¸…å–®

| è«–æ–‡                    | ä¾†æº               | ç‹€æ…‹             | é¸æ“‡ç†ç”±                     |
| ----------------------- | ------------------ | ---------------- | ---------------------------- |
| Peixoto et al. (2025)   | IJCAI XAI Workshop | âœ… å·²æ”¶é›†ï¼ŒTier 1 | XAI å¯åŠæ€§â€”â€”èˆ‡è€å¹´äººé«˜åº¦ç›¸é—œ |
| **NIST AI RMF (2023)**  | NIST å®˜ç¶²          | âœ… **å·²ä¸‹è¼‰**     | AI é¢¨éšªç®¡ç†æ¡†æ¶              |
| **WHO Guidance (2021)** | WHO å®˜ç¶²           | âœ… **å·²ä¸‹è¼‰**     | AI å¥åº·å€«ç†èˆ‡æ²»ç†æŒ‡å—        |
| **Amii (2023)**         | Amii å®˜ç¶²          | âŒ å¾…ä¸‹è¼‰         | åŠ æ‹¿å¤§è² è²¬ä»» AI å¯¦è¸         |
| **CIFAR (2022)**        | CIFAR å®˜ç¶²         | âŒ å¾…ä¸‹è¼‰         | å¯ä¿¡è³´ AI å ±å‘Š               |
| Bhattacharya (2024)     | CHI EA             | â³ å¾…ç¢ºèª         | ç‚ºéæŠ€è¡“ç”¨æˆ¶è¨­è¨ˆ XAI         |

### ç•¶å‰è¦†è“‹ç‡ï¼š~75% ğŸŸ¢ï¼ˆ3ç¯‡å·²æ”¶é›†ï¼Œå«2ä»½ç°è‰²æ–‡ç»ï¼‰

### ç°è‰²æ–‡ç»æ”¶é›†æƒ…æ³

| æ–‡ç»                    | ç‹€æ…‹         | ä¸‹è¼‰é€£çµ                                                              |
| ----------------------- | ------------ | --------------------------------------------------------------------- |
| **NIST AI RMF (2023)**  | âœ… **å·²ä¸‹è¼‰** | https://nvlpubs.nist.gov/nistpubs/ai/NIST.AI.100-1.pdf                |
| **WHO Guidance (2021)** | âœ… **å·²ä¸‹è¼‰** | https://www.who.int/publications/i/item/9789240029200                 |
| **CIFAR (2023)**        | âœ… **å·²ä¸‹è¼‰** | https://cifar.ca/wp-content/uploads/2023/11/aican-impact-2023-eng.pdf |
| **Amii (2023)**         | âœ… **å·²ä¸‹è¼‰** | https://www.amii.ca/about/principled-ai                               |

**å·²å®Œæˆ**ï¼šNISTã€WHOã€CIFAR å’Œ Amii å››ä»½æ ¸å¿ƒæ¡†æ¶æ–‡ä»¶å·²æˆåŠŸä¸‹è¼‰ä¸¦å°å…¥ Zoteroï¼Œç‚ºåˆ†æã€Œé«˜å±¤åŸå‰‡èˆ‡ç•Œé¢å±¤å¯¦ç¾å·®è·ã€æä¾›äº†åŸºæº–åƒç…§ã€‚

---

# å››ã€æœç´¢çµæœåˆ†æ

## 4.1 æœç´¢è¦†è“‹ç‡ç¸½è¦½

| ä¸»é¡Œé ˜åŸŸ                                     | ç›®æ¨™   | å¯¦éš›æ”¶é›†                                                                    | è¦†è“‹ç‡ | è©•ä¼°             |
| -------------------------------------------- | ------ | --------------------------------------------------------------------------- | ------ | ---------------- |
| ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰    | 5-8 ç¯‡ | 8 ç¯‡å·²æ”¶é›†ï¼ˆ3ç¯‡ Tier 2ï¼Œ2ç¯‡ Tier 3ï¼Œ1ç¯‡ Tier 1ï¼Œ1ç¯‡ Unacceptedï¼Œ1ç¯‡å¾…è©•ä¼°ï¼‰ | ~100%  | ğŸŸ¢ è‰¯å¥½           |
| ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±                    | 5-8 ç¯‡ | 3 ç¯‡å·²æ”¶é›†ä¸¦å®Œæˆè©•ä¼°ï¼ˆå…¨éƒ¨ Tier 1ï¼‰âœ…                                        | ~60%   | ğŸŸ¢ æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ |
| ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº | 5-8 ç¯‡ | 6 ç¯‡å·²æ”¶é›†ï¼ˆ1ç¯‡ Tier 2ï¼Œ5ç¯‡ Unacceptedï¼‰                                    | ~20%   | ğŸŸ¡ éœ€è£œå……         |
| ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI                | 5-8 ç¯‡ | 6 ç¯‡å·²æ”¶é›†ï¼ˆ2ç¯‡ Tier 1ï¼Œ4ç¯‡ç°è‰²æ–‡ç»ï¼‰âœ…                                      | ~80%   | ğŸŸ¢ è‰¯å¥½           |

## 4.2 å¯¦éš›æ”¶é›†æ–‡ç»æ¸…å–®

### ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰

1. **Zubatiy et al. (2023)** - "I don't know how to help with that" - PACM HCI (CSCW2) - âœ… **Tier 2**
2. **Brewer et al. (2022)** - "An Empirical Study of Older Adult's Voice Assistant Use for Health Information Seeking" - ACM TiiS - âœ… **Tier 3**
3. **An et al. (2025)** - "Conversational Agents for Older Adults' Health: A Systematic Literature Review" - arXiv - âœ… **Tier 2**
4. **Even et al. (2022)** - "Benefits and challenges of conversational agents in older adults" - Z Gerontol Geriatr - âœ… **Tier 2**
5. **Martin-Hammond et al. (2019)** - "Exploring Older Adults' Beliefs About the Use of Intelligent Assistants" - JMIR Aging - âŒ **Unaccepted**ï¼ˆåƒ…æ¢ç´¢æ…‹åº¦ä¿¡å¿µï¼Œæœªåˆ†æç•Œé¢è¨­è¨ˆå½±éŸ¿ï¼‰

**æ–°å¢æ–‡ç»ï¼ˆRound 2ï¼‰**ï¼š
6. **Huang et al. (2025)** - "Designing Conversational AI for Aging: A Systematic Review" - CHI 2025 - â³ å¾…è©•ä¼°
7. **Du et al. (2024)** - "Enhancing Older Adults' Lives with Conversational Agents" - Chinese CHI 2024 - âœ… **Tier 3**
8. **Brewer (2022) CHI EA** - "If Alexa knew the state I was in, it would cry" - CHI EA 2022 - âœ… **Tier 1**ï¼ˆä¸‰ç¶­åº¦è¦†è“‹ï¼šPersuasive Design, Usability, Transparencyï¼‰

### ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±

1. **Gray et al. (2018)** - "The Dark (Patterns) Side of UX Design" - CHI 2018 - âœ… **Tier 1**
   - DOI: https://doi.org/10.1145/3173574.3174108
   - æš—é»‘æ¨¡å¼çš„å¥ åŸºæ€§ç ”ç©¶ï¼Œæä¾›åˆ†é¡ç³»çµ±
   - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern identification, trust/exploitation, design/analysis
2. **Susser et al. (2019)** - "Technology, Autonomy, and Manipulation" - Internet Policy Review - âœ… **Tier 1**
   - DOI: https://doi.org/10.14763/2019.2.1410
   - æŠ€è¡“æ“ç¸±çš„ç†è«–æ¡†æ¶ï¼Œå€åˆ†åˆæ³•å½±éŸ¿èˆ‡æ“ç¸±æ€§å¯¦è¸
   - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/autonomy, trust/manipulation, design/ethics
3. **Brignull (2023/2024)** - "Deceptive Patterns: exposing the tricks tech companies use to control you" - Book (Testimonium Ltd) - âœ… **Tier 1**
   - Publisher: Testimonium Ltd (Eastbourne, England)
   - Edition: First edition: 2 January 2024
   - ISBN: 978-1-7394544-1-8, 978-1-7394544-0-1, 978-1-7394544-2-5
   - å·²ä»¥ epub æ ¼å¼æ”¶éŒ„ä¸¦æ›´æ–°è‡³ Zotero
   - æ¬ºé¨™æ€§è¨­è¨ˆçš„å¯¦è¸åˆ†é¡ï¼Œæä¾›å¯¦ç”¨æ¡†æ¶è­˜åˆ¥å’Œåˆ†ææ“ç¸±æ€§è¨­è¨ˆå…ƒç´ 
   - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern recognition, trust/deception, design/practice

**å®Œæˆç‹€æ…‹**ï¼šâœ… æ‰€æœ‰æ ¸å¿ƒæ–‡ç»å·²å®Œæˆ Tier è©•ä¼°ï¼Œå…¨éƒ¨è©•ç‚º Tier 1

### ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº

1. **Ellis et al. (2025)** - "The Halo Effect: Perceptions of Information Privacy Among Healthcare Chatbot Users" - J Am Geriatr Soc - âŒ **Unaccepted**
   - **æ’é™¤ç†ç”±**ï¼šéš±ç§æ„ŸçŸ¥ç ”ç©¶é›–ç„¶é‡è¦ï¼Œä½†å¦‚æœæ–‡ç»æœªé€£çµåˆ°**ç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿éš±ç§é¢¨éšªæ„ŸçŸ¥**ï¼ˆé€æ˜åº¦ç¶­åº¦ï¼‰ï¼Œå‰‡ç„¡æ³•ç›´æ¥æ”¯æŒç ”ç©¶è«–è­‰ã€‚Ellis et al. (2025) æä¾›äº†è€å¹´äººå› ä¿¡ä»»é†«ç™‚æ©Ÿæ§‹è€Œä½ä¼°éš±ç§é¢¨éšªçš„å¯¦è­‰è­‰æ“šï¼ˆhalo effectï¼‰ï¼Œä½†æœªåˆ†æå…·é«”çš„ç•Œé¢è¨­è¨ˆå…ƒç´ ï¼ˆå¦‚é€æ˜åº¦æ©Ÿåˆ¶ã€èªªæœè¨­è¨ˆæ¨¡å¼ï¼‰å¦‚ä½•å¡‘é€ æˆ–åˆ©ç”¨é€™ç¨®æ„ŸçŸ¥åå·®ã€‚
   - **ç ”ç©¶å•é¡Œå½±éŸ¿**ï¼šæ­¤æ’é™¤å°ç ”ç©¶å•é¡Œçš„è«–è­‰é‚è¼¯æœ‰é‡è¦å½±éŸ¿ã€‚åŸè¨ˆåŠƒä¸­ï¼ŒEllis et al. (2025) è¢«è¦–ç‚ºã€Œç›´æ¥æ”¯æŒç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ–‡ç»ã€ï¼Œå› ç‚ºå®ƒæä¾›äº†è€å¹´äººéš±ç§æ„ŸçŸ¥åå·®çš„å¯¦è­‰è­‰æ“šã€‚ç„¶è€Œï¼ŒRound 2 è©•ä¼°å¼·èª¿ç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ˜¯ã€Œ**ç•Œé¢è¨­è¨ˆå¯¦è¸çš„ç¼ºå£**ã€ï¼Œè€Œéåƒ…æ˜¯æ„ŸçŸ¥åå·®çš„å­˜åœ¨ã€‚å› æ­¤ï¼Œéœ€è¦å°‹æ‰¾**åŒæ™‚æ¶µè“‹éš±ç§æ„ŸçŸ¥åå·®å’Œç•Œé¢è¨­è¨ˆå½±éŸ¿**çš„æ–‡ç»ï¼Œæˆ–èª¿æ•´ç ”ç©¶å•é¡Œçš„è¡¨è¿°ä»¥æ˜ç¢ºå€åˆ†ã€Œæ„ŸçŸ¥å•é¡Œã€èˆ‡ã€Œè¨­è¨ˆå•é¡Œã€ã€‚
   - **æ›¿ä»£æ–¹æ¡ˆ**ï¼šéœ€è¦å°‹æ‰¾èšç„¦æ–¼ã€Œç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿è€å¹´äººéš±ç§é¢¨éšªæ„ŸçŸ¥ã€çš„æ–‡ç»ï¼Œæˆ–ã€Œè¨­è¨ˆå¹²é å¦‚ä½•ç³¾æ­£æ„ŸçŸ¥åå·®ã€çš„ç ”ç©¶ã€‚
2. **Wildenbos et al. (2018)** - "Aging barriers influencing mobile health usability for older adults: A literature based framework (MOLD-US)" - Int J Med Inform - âœ… **Tier 2**
   - DOI: https://doi.org/10.1016/j.ijmedinf.2018.03.012
   - ä¸‰ç¶­åº¦è¦†è“‹ï¼šUsability/Harm (é«˜åº¦ç›¸é—œ), Transparency/Trust (é–“æ¥ç›¸é—œ), Persuasive Design/Manipulation (æ½›åœ¨ç›¸é—œä½†æœªæ˜ç¢º)
   - MOLD-US æ¡†æ¶ç³»çµ±æ€§è­˜åˆ¥å››å¤§é¡è€å¹´éšœç¤™ï¼ˆCognition, Motivation, Physical Ability, Perceptionï¼‰ï¼Œå¯ç›´æ¥æ‡‰ç”¨æ–¼åˆ†æå°è©±ä»£ç†çš„å¯ç”¨æ€§å•é¡Œ
   - é«˜å½±éŸ¿åŠ›ï¼ˆ555+ æ¬¡å¼•ç”¨ï¼‰ï¼Œæ˜¯è©²é ˜åŸŸçš„æ¨™æº–åƒè€ƒæ–‡ç»
3. **Sakaguchi-Tang et al. (2017)** - "Patient Portal Use and Experience Among Older Adults: Systematic Review" - JMIR Med Inform - âŒ **Unaccepted**ï¼ˆä¸»è¦èšç„¦å‚³çµ± GUI å¯ç”¨æ€§éšœç¤™ï¼Œéå°è©±ä»£ç†ï¼‰
4. **Kidman et al. (2024)** - "When and Why Adults Abandon Lifestyle Behavior and Mental Health Mobile Apps" - JMIR - âŒ **Unaccepted**ï¼ˆå¾è¡Œç‚ºç§‘å­¸è€Œéç•Œé¢è¨­è¨ˆè¦–è§’åˆ†æï¼‰
5. **Ma et al. (2023)** - "Artificial intelligence in elderly healthcare: A scoping review" - Ageing Res Rev - âŒ **Unaccepted**ï¼ˆèšç„¦ AI æŠ€è¡“æ‡‰ç”¨è€Œéäº¤äº’è¨­è¨ˆï¼‰
6. **Turner et al. (2020)** - "Patient Portal Barriers and Group Differences" - JMIR - âŒ **Unaccepted**ï¼ˆç¼ºä¹ AI é€æ˜åº¦æˆ–èªªæœè¨­è¨ˆè¨è«–ï¼‰

**é‡è¦èªªæ˜**ï¼šä¸»é¡Œä¸‰çš„å¤šæ•¸æ–‡ç»åœ¨ Round 2 è©•ä¼°ä¸­è¢«æ¨™è¨˜ç‚º Unacceptedï¼Œå› ç‚ºå®ƒå€‘æœªç›´æ¥é€£çµåˆ°å°è©±å¼ AI çš„ç•Œé¢è¨­è¨ˆæˆ–ä¸‰ç¶­åº¦åˆ†ææ¡†æ¶ã€‚Wildenbos et al. (2018) çš„ MOLD-US æ¡†æ¶å·²è©•ç‚º Tier 2ï¼Œæä¾›çµæ§‹åŒ–æ–¹æ³•è­˜åˆ¥å’Œåˆ†æè€å¹´ç”¨æˆ¶çš„å¯ç”¨æ€§éšœç¤™ï¼Œä½†éœ€æ‰¹åˆ¤æ€§æ“´å±•ä»¥æ¶µè“‹å°è©±ä»£ç†æƒ…å¢ƒä¸‹çš„é€æ˜åº¦å’Œèªªæœè¨­è¨ˆç¶­åº¦ã€‚

**é—œéµè®ŠåŒ–**ï¼šEllis et al. (2025) å¾åŸè¨ˆåŠƒçš„ã€Œæ ¸å¿ƒæ–‡ç»ã€è½‰ç‚ºã€ŒUnacceptedã€ï¼Œåæ˜ äº†è©•ä¼°æ¨™æº–çš„åš´æ ¼åŒ–ï¼šç ”ç©¶å•é¡Œçš„æ ¸å¿ƒæ˜¯ã€Œ**ç•Œé¢è¨­è¨ˆå¯¦è¸çš„ç¼ºå£**ã€ï¼Œè€Œéåƒ…æ˜¯ã€Œæ„ŸçŸ¥å•é¡Œçš„å­˜åœ¨ã€ã€‚é€™è¦æ±‚æ–‡ç»å¿…é ˆæ˜ç¢ºé€£çµç•Œé¢è¨­è¨ˆå…ƒç´ èˆ‡ç ”ç©¶å•é¡Œçš„ä¸‰å€‹ç¶­åº¦ï¼ˆharm, trust, designï¼‰ã€‚

### ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI

1. **Peixoto et al. (2025)** - "Who Benefits from AI Explanations? Towards Accessible and Interpretable Systems" - IJCAI XAI Workshop - âœ… **Tier 1**
2. **Bhattacharya (2024)** - "Towards Directive Explanations: Crafting Explainable AI Systems" - CHI EA 2024 - âœ… **Tier 1**ï¼ˆä¸‰ç¶­åº¦è¦†è“‹ï¼šAI Explainability/Transparency, Persuasive Design, Usabilityï¼‰
3. **NIST AI RMF (2023)** - "Artificial Intelligence Risk Management Framework" - NISTï¼ˆç°è‰²æ–‡ç»ï¼‰âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero
4. **WHO Guidance (2021)** - "Ethics and Governance of Artificial Intelligence for Health" - WHOï¼ˆç°è‰²æ–‡ç»ï¼‰âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero
5. **CIFAR (2023)** - "AICan: The Impact of the Pan-Canadian AI Strategy" - CIFARï¼ˆç°è‰²æ–‡ç»ï¼‰âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero
   - URL: https://cifar.ca/wp-content/uploads/2023/11/aican-impact-2023-eng.pdf
6. **Amii (2023)** - "Principled AI at Amii" - Amii å®˜ç¶²ï¼ˆç°è‰²æ–‡ç»ï¼‰âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero
   - URL: https://www.amii.ca/about/principled-ai

## 4.3 è«–æ–‡è³ªé‡åˆ†å¸ƒï¼ˆæ›´æ–°ï¼šåŸºæ–¼ Round 2 è©•ä¼°ï¼Œä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å®Œæˆè©•ä¼°ï¼‰

åŸºæ–¼ Tier åˆ†ç´šç³»çµ±ï¼ˆRound 2 è©•ä¼°çµæœï¼‰ï¼š

| è³ªé‡å±¤ç´š             | æ•¸é‡ | ç™¾åˆ†æ¯” | è©•ä¼°                  |
| -------------------- | ---- | ------ | --------------------- |
| Tier 1ï¼ˆä¸‰ç¶­åº¦è¦†è“‹ï¼‰ | 6 ç¯‡ | 29%    | ğŸŸ¡ åä½ï¼ˆç†æƒ³ 40-50%ï¼‰ |
| Tier 2ï¼ˆéƒ¨åˆ†è¦†è“‹ï¼‰   | 4 ç¯‡ | 19%    | ğŸŸ¡ éœ€è£œå……              |
| Tier 3ï¼ˆå–®ä¸€ç¶­åº¦ï¼‰   | 1 ç¯‡ | 5%     | ğŸŸ¢ å·²åˆ†é¡              |
| Unacceptedï¼ˆæ’é™¤ï¼‰   | 7 ç¯‡ | 33%    | âœ… å·²æ˜ç¢ºæ’é™¤          |
| å¾…è©•ä¼°/æœªåˆ†é¡        | 3 ç¯‡ | 14%    | ğŸŸ¡ éœ€å®Œæˆè©•ä¼°          |

**Tier 1 æ–‡ç»ï¼ˆ6ç¯‡ï¼‰**ï¼š
1. **Peixoto et al. (2025)** - "Who Benefits from AI Explanations?" - ä¸‰ç¶­åº¦è¦†è“‹ï¼šAI Explainability/Transparency, Usability, Persuasive Design (implicit)
2. **Bhattacharya (2024)** - "Towards Directive Explanations" - ä¸‰ç¶­åº¦è¦†è“‹ï¼šAI Explainability/Transparency, Persuasive Design, Usability
3. **Brewer (2022) CHI EA** - "If Alexa knew the state I was in" - ä¸‰ç¶­åº¦è¦†è“‹ï¼šPersuasive Design, Usability, Transparency
4. **Gray et al. (2018)** - "The Dark (Patterns) Side of UX Design" - âœ… **Tier 1** - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern identification, trust/exploitation, design/analysis
5. **Susser et al. (2019)** - "Technology, Autonomy, and Manipulation" - âœ… **Tier 1** - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/autonomy, trust/manipulation, design/ethics
6. **Brignull (2023/2024)** - "Deceptive Patterns" - âœ… **Tier 1** - ä¸‰ç¶­åº¦è¦†è“‹ï¼šharm/pattern recognition, trust/deception, design/practice

**Tier 2 æ–‡ç»ï¼ˆ4ç¯‡ï¼‰**ï¼š
1. **An et al. (2025)** - "Conversational Agents for Older Adults' Health" - ç³»çµ±æ€§æ–‡ç»å›é¡§ï¼Œè¦†è“‹ Usabilityï¼ŒTransparency å’Œ Persuasive Design éœ€ç¢ºèª
2. **Zubatiy et al. (2023)** - "I don't know how to help with that" - è¦†è“‹ Usability, Transparency (indirect), Persuasive Design (gap)
3. **Even et al. (2022)** - "Benefits and challenges of conversational agents" - è¦†è“‹ Usability, Transparency (implicit), Persuasive Design (gap)
4. **Wildenbos et al. (2018)** - "Aging barriers influencing mobile health usability" - âœ… **Tier 2** - MOLD-US æ¡†æ¶ï¼šUsability/Harm (é«˜åº¦ç›¸é—œ), Transparency/Trust (é–“æ¥ç›¸é—œ), Persuasive Design/Manipulation (æ½›åœ¨ç›¸é—œä½†æœªæ˜ç¢º)

**Tier 3 æ–‡ç»ï¼ˆ1ç¯‡ï¼‰**ï¼š
1. **Brewer et al. (2022)** - "An Empirical Study of Older Adult's Voice Assistant Use" - æä¾›å¯¦è­‰æ•¸æ“šï¼Œè¦†è“‹ Usability, Transparency, Persuasive Design

**Unaccepted æ–‡ç»ï¼ˆ7ç¯‡ï¼‰**ï¼š
1. Chen & Wen (2024) - Mental health scoping review - æœªæ·±å…¥è¨è«–ä¸‰ç¶­åº¦äº¤äº’
2. Martin-Hammond et al. (2019) - åƒ…æ¢ç´¢æ…‹åº¦ä¿¡å¿µï¼Œæœªåˆ†æç•Œé¢è¨­è¨ˆå½±éŸ¿
3. Ma et al. (2023) - èšç„¦ AI æŠ€è¡“æ‡‰ç”¨è€Œéäº¤äº’è¨­è¨ˆ
4. Ellis et al. (2025) - Halo Effect - æœªé€£çµç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿éš±ç§é¢¨éšªæ„ŸçŸ¥
5. Turner et al. (2020) - Patient Portal Barriers - ç¼ºä¹ AI é€æ˜åº¦æˆ–èªªæœè¨­è¨ˆè¨è«–
6. Sakaguchi-Tang et al. (2017) - Patient Portal Use - ä¸»è¦èšç„¦å‚³çµ± GUI å¯ç”¨æ€§éšœç¤™
7. Kidman et al. (2024) - App abandonment - å¾è¡Œç‚ºç§‘å­¸è€Œéç•Œé¢è¨­è¨ˆè¦–è§’åˆ†æ

## 4.3 æœç´¢ç­–ç•¥æœ‰æ•ˆæ€§åˆ†æ

### æœ‰æ•ˆçš„æœç´¢

```
âœ… ("older adults" OR elderly) AND (AI OR "artificial intelligence") 
   AND (health OR healthcare)
   â†’ æˆåŠŸæ‰¾åˆ°ï¼šMa et al. 2023, Ellis et al. 2025, An et al. 2025

âœ… ("older adults") AND ("intelligent systems" OR "conversational agents")
   â†’ æˆåŠŸæ‰¾åˆ°ï¼šZubatiy et al. 2023, Brewer et al. 2022, Even et al. 2022

âœ… "explainable AI" OR XAI AND accessibility
   â†’ æˆåŠŸæ‰¾åˆ°ï¼šPeixoto et al. 2025

âœ… "MOLD-US" OR "Wildenbos"
   â†’ æˆåŠŸæ‰¾åˆ°ï¼šWildenbos et al. 2018

âœ… ç›´æ¥ä¸‹è¼‰ç°è‰²æ–‡ç»
   â†’ æˆåŠŸä¸‹è¼‰ï¼šNIST AI RMF (2023), WHO Guidance (2021)
```

### æœªåŸ·è¡Œæˆ–æ•ˆæœä¸ä½³çš„æœç´¢

```
âŒ "dark patterns" (ä¸»é¡ŒäºŒ)
   â†’ çµæœï¼šå ±å‘Šä¸­ç„¡æ˜ç¢ºæš—é»‘æ¨¡å¼è«–æ–‡

âŒ "deceptive design" OR "manipulative design" (ä¸»é¡ŒäºŒ)
   â†’ çµæœï¼šå ±å‘Šä¸­ç„¡ç›¸é—œè«–æ–‡

âœ… é™å®šç‰¹å®šä½œè€…æœç´¢ï¼ˆColin Gray, Daniel Susserï¼‰
   â†’ çµæœï¼šå·²æˆåŠŸå®šä½ä¸¦ä¸‹è¼‰ Gray et al. (2018) å’Œ Susser et al. (2019) âœ…
```

---

# äº”ã€ç¾ç‹€åˆ†æèˆ‡æ”¹é€²ç­–ç•¥

## 5.1 ä¸»é¡ŒäºŒæš—é»‘æ¨¡å¼æ–‡ç»æ”¶é›†ç‹€æ…‹ï¼ˆæ›´æ–°ï¼šæ ¸å¿ƒæ–‡ç»å·²å®Œæˆï¼‰

### ç¾ç‹€åˆ†æ

ç ”ç©¶è¨ˆåŠƒæ›¸çš„åˆæ­¥æ›¸ç›®ä¸­å·²åˆ—å‡º Gray et al. (2018)ã€Susser et al. (2019) å’Œ Brignull (2024) ä½œç‚ºæ ¸å¿ƒæ–‡ç»ã€‚âœ… **å·²å®Œæˆ**ï¼šé€šéé‡å°æ€§çš„ä½œè€…åæœç´¢å’Œç›´æ¥è¨ªå•æœŸåˆŠ/å‡ºç‰ˆç¤¾ç¶²ç«™ï¼Œå·²æˆåŠŸå®šä½ã€ä¸‹è¼‰ä¸¦è©•ä¼°ä»¥ä¸‹æ ¸å¿ƒæ–‡ç»ï¼š

- âœ… **Gray et al. (2018)** - å·²æ·»åŠ è‡³ Zoteroï¼Œå·²è©•ä¼°ç‚º **Tier 1**
- âœ… **Susser et al. (2019)** - å·²æ·»åŠ è‡³ Zoteroï¼Œå·²è©•ä¼°ç‚º **Tier 1**
- âœ… **Brignull (2023/2024)** - å·²æ·»åŠ è‡³ Zoteroï¼Œå·²è©•ä¼°ç‚º **Tier 1**

**ç•¶å‰è¦†è“‹ç‡**ï¼š60% (3/5 ç¯‡æ ¸å¿ƒæ–‡ç»)ã€‚æ ¸å¿ƒç†è«–åŸºç¤å·²å»ºç«‹ï¼Œä»éœ€è£œå…… 1-2 ç¯‡æ–‡ç»ä»¥é”åˆ° 80-100% ç›®æ¨™ã€‚

### æˆåŠŸç¶“é©—ç¸½çµï¼ˆæ›´æ–°ï¼šæ ¸å¿ƒæ–‡ç»å·²å®Œæˆï¼‰

**âœ… æˆåŠŸç­–ç•¥**ï¼š

1. **ä½œè€…åæœç´¢**ï¼šä½¿ç”¨ä½œè€…åï¼ˆ"Colin Gray"ã€"Daniel Susser"ï¼‰é€²è¡Œç²¾ç¢ºå®šä½ï¼ŒæˆåŠŸæ‰¾åˆ° Gray et al. (2018) å’Œ Susser et al. (2019)
2. **ç›´æ¥è¨ªå•æœŸåˆŠ/å‡ºç‰ˆç¤¾ç¶²ç«™**ï¼šé€šé Internet Policy Review ç¶²ç«™å’Œ Testimonium Ltd å‡ºç‰ˆç¤¾ç›´æ¥ç²å–æ–‡ç»
3. **æ•¸æ“šåº«é¸æ“‡**ï¼šåœ¨ ACM Digital Library åŸ·è¡Œå°ˆé …æœç´¢ï¼ŒæˆåŠŸå®šä½ CHI 2018 è«–æ–‡
4. **éå­¸è¡“ä¾†æºç¢ºèª**ï¼šç¢ºèª Brignull (2024) ç‚ºæ›¸ç±ï¼ˆTestimonium Ltdï¼‰ï¼Œå·²ä»¥ epub æ ¼å¼æ”¶éŒ„

**âœ… å·²å®Œæˆçš„æ ¸å¿ƒæ–‡ç»**ï¼š

- **Gray et al. (2018)**ï¼šâœ… å·²é€šé ACM Digital Library ä¸‹è¼‰ï¼Œå·²è©•ä¼°ç‚º Tier 1
- **Susser et al. (2019)**ï¼šâœ… å·²é€šé Internet Policy Review ç¶²ç«™ä¸‹è¼‰ï¼Œå·²è©•ä¼°ç‚º Tier 1
- **Brignull (2023/2024)**ï¼šâœ… å·²ç¢ºèªç‚ºæ›¸ç±ï¼ˆTestimonium Ltdï¼‰ï¼Œå·²ä»¥ epub æ ¼å¼æ”¶éŒ„ï¼Œå·²è©•ä¼°ç‚º Tier 1

### è£œå……ç­–ç•¥ï¼ˆé”åˆ° 80-100% è¦†è“‹ç‡ï¼‰

**ç­–ç•¥ 2ï¼šåˆ†å±¤æœç´¢æ³•ï¼ˆè£œå……å…¶ä»–æ–‡ç»ï¼‰**

```
ç¬¬ä¸€æ­¥ï¼ˆå¯¬æ³›ï¼‰ï¼š
"dark patterns" OR "deceptive design" OR "manipulative design"
â†’ å…ˆå»ºç«‹æš—é»‘æ¨¡å¼çš„åŸºç¤æ–‡ç»åº«ï¼ˆä¸é™å¥åº·æˆ–è€å¹´äººï¼‰

ç¬¬äºŒæ­¥ï¼ˆä¸­ç­‰ï¼‰ï¼š
("dark patterns" OR "deceptive design") AND (digital health OR eHealth)
â†’ ç¸®å°åˆ°å¥åº·é ˜åŸŸ

ç¬¬ä¸‰æ­¥ï¼ˆç²¾ç¢ºï¼‰ï¼š
("dark patterns") AND ("consent" OR "privacy" OR "autonomy")
â†’ èšç„¦æ–¼èˆ‡ç ”ç©¶å•é¡Œç›¸é—œçš„å€«ç†ç¶­åº¦
```

**ç­–ç•¥ 3ï¼šæœƒè­°å°ˆé …æœç´¢**

```
ACM Digital Library:
- Conference: CHI (2018-2025) + "dark patterns"
- Conference: FAccT (2020-2025) + "manipulation" OR "autonomy"
- Conference: DIS (2018-2025) + "deceptive design"
```

---

## 5.2 éåº¦æ’é™¤ç›¸é—œè«–æ–‡

### ç¾ç‹€åˆ†æ

éƒ¨åˆ†æ¨™è¨˜ç‚º Unaccepted çš„è«–æ–‡æ‡‰é‡æ–°è€ƒæ…®ï¼š

**æ¡ˆä¾‹ï¼šEllis et al. (2025) - "The Halo Effect"**

| é …ç›®         | å…§å®¹                                                                                                                                                        |
| ------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
| åŸæ’é™¤ç†ç”±   | ã€Œå¦‚æœä¸é€£çµç•Œé¢è¨­è¨ˆå¦‚ä½•å½±éŸ¿éš±ç§é¢¨éšªæ„ŸçŸ¥å‰‡æ’é™¤ã€                                                                                                            |
| å•é¡Œ         | æ¨™æº–éæ–¼åš´æ ¼                                                                                                                                                |
| ç‚ºä»€éº¼æ‡‰ç´å…¥ | 1. æä¾›è€å¹´äººéš±ç§æ„ŸçŸ¥åå·®çš„å¯¦è­‰è­‰æ“š<br>2. ç›´æ¥æ”¯æŒç ”ç©¶å•é¡Œï¼ˆè¨­è¨ˆæœªè€ƒæ…®éš±ç§é¢¨éšªæ„ŸçŸ¥ï¼‰<br>3. æä¾›æ¦‚å¿µæ¡†æ¶ï¼ˆhalo effectï¼‰ç”¨æ–¼åˆ†æè¨­è¨ˆå¤±æ•ˆ<br>4. å¼•æ–‡è¿½è¹¤çš„èµ·é» |

### æ”¹é€²çš„ç´å…¥/æ’é™¤æ¨™æº–

| æ¨™æº–ç¶­åº¦       | ç¨®å­è«–æ–‡                         | èƒŒæ™¯è«–æ–‡             | æ’é™¤           |
| -------------- | -------------------------------- | -------------------- | -------------- |
| HCI æ·±åº¦       | æœ‰æ˜ç¢ºçš„ç•Œé¢/äº¤äº’è¨­è¨ˆè¨è«–        | æåˆ°è¨­è¨ˆä½†ä¸æ·±å…¥     | å®Œå…¨ç„¡è¨­è¨ˆè¦–è§’ |
| ç”¨æˆ¶ç¾¤ç›¸é—œæ€§   | å°ˆæ³¨è€å¹´äººæˆ–æœ‰è€å¹´äººå­æ¨£æœ¬       | ä¸€èˆ¬æˆå¹´äººï¼ˆå¯æ¨å»£ï¼‰ | å…’ç«¥ã€å°ˆæ¥­ç”¨æˆ¶ |
| å¥åº·é ˜åŸŸç›¸é—œæ€§ | å¥åº·/é†«ç™‚æ‡‰ç”¨ç‚ºä¸»                | åŒ…å«å¥åº·æ¡ˆä¾‹         | å®Œå…¨ç„¡é—œ       |
| å¼•æ–‡åƒ¹å€¼       | è¢«å¼•>10 æˆ–å¼•ç”¨>20 ç¯‡ç›¸é—œæ–‡ç»     | è¢«å¼•<10              | å¼•æ–‡è²§ä¹       |
| å•é¡Œç›¸é—œæ€§     | ç›´æ¥è§£æ±ºæˆ–æš´éœ²ç ”ç©¶å•é¡Œçš„æŸå€‹é¢å‘ | æä¾›æ¦‚å¿µ/æ–¹æ³•è«–æ”¯æŒ  | å®Œå…¨ä¸ç›¸é—œ     |

**é—œéµåŸå‰‡**ï¼š
- **ç¨®å­è«–æ–‡éšæ®µ**ï¼šç´å…¥æ¨™æº–æ‡‰è©²**å¯¬é¬†**â€”â€”ç›®æ¨™æ˜¯å»ºç«‹å¼•æ–‡ç¶²çµ¡çš„èµ·é»
- **Week 3-6 å¼•æ–‡è¿½è¹¤éšæ®µ**ï¼šå†ç”¨åš´æ ¼æ¨™æº–ç¯©é¸æ“´å±•æ–‡ç»
- **Week 7-10 æ·±åº¦åˆ†æéšæ®µ**ï¼šåƒ…ä¿ç•™æœ€æ ¸å¿ƒçš„ 40-50 ç¯‡

---

## 5.3 æ•¸æ“šåº«é¸æ“‡èˆ‡æœç´¢ç¯„åœ

### ç¾ç‹€åˆ†æ

**è§€å¯Ÿåˆ°çš„è«–æ–‡ä¾†æºåˆ†å¸ƒ**ï¼š
- âœ… ACM æœƒè­°/æœŸåˆŠï¼šCHI, CSCW, TiiS â†’ è¦†è“‹è‰¯å¥½
- âœ… JMIR ç³»åˆ— â†’ è¦†è“‹è‰¯å¥½
- ğŸŸ¡ IEEE æœƒè­°ï¼šè¼ƒå°‘å‡ºç¾
- âŒ é ˜åŸŸç‰¹å®šæœŸåˆŠï¼šGerontechnology, Universal Access in the Information Society

**å¯èƒ½çš„å•é¡Œ**ï¼š
1. éåº¦ä¾è³´å–®ä¸€æ•¸æ“šåº«
2. æœªå……åˆ†åˆ©ç”¨ IEEE Xploreï¼ˆAI å€«ç†è«–æ–‡å¸¸åœ¨æ­¤ï¼‰
3. æœªæœç´¢ Scopus çš„ "Conference Proceedings" ç¯©é¸å™¨

### æ”¹é€²çš„æ•¸æ“šåº«ä½¿ç”¨ç­–ç•¥

| ä¸»é¡Œ                                         | é¦–é¸æ•¸æ“šåº«              | æ¬¡é¸æ•¸æ“šåº«              | è£œå……ä¾†æº               |
| -------------------------------------------- | ----------------------- | ----------------------- | ---------------------- |
| ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰    | ACM DL                  | Scopus (Comp Sci)       | ASSETS Digital Archive |
| ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±                    | **ACM DLï¼ˆå¿…é ˆï¼‰**      | IEEE Xplore             | Google Scholar         |
| ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº | Web of Science (Health) | JMIR Publications       | PubMed                 |
| ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI                | **çµ„ç¹”å®˜ç¶²**            | IEEE Xplore (Standards) | arXiv                  |

---

## 5.4 èˆ‡ç ”ç©¶å•é¡Œçš„å°é½Šåº¦æª¢æŸ¥

### äº”å€‹é—œéµç¶­åº¦çš„è¦†è“‹åº¦

| é—œéµç¶­åº¦          | éœ€è¦çš„æ–‡ç»é¡å‹                | ç•¶å‰è¦†è“‹                      | ç¼ºå£                       |
| ----------------- | ----------------------------- | ----------------------------- | -------------------------- |
| 1. è€å¹´äºº AI ç´ é¤Š | è€å¹´äººç†è§£/èª¤è§£ AI çš„å¯¦è­‰ç ”ç©¶ | ğŸŸ¡ ä¸­ç­‰                        | ç¼ºå°‘ AI ç´ é¤Šæ¸¬é‡ç ”ç©¶       |
| 2. éš±ç§é¢¨éšªæ„ŸçŸ¥   | è€å¹´äººéš±ç§æ„ŸçŸ¥çš„åå·®          | ğŸŸ¢ è‰¯å¥½ï¼ˆEllis 2025 å¦‚æœç´å…¥ï¼‰ | éœ€è¦æ›´å¤šè¨­è¨ˆå½±éŸ¿æ„ŸçŸ¥çš„ç ”ç©¶ |
| 3. è¨­è¨ˆå¯¦è¸ç¼ºå£   | æ‰¹åˆ¤æ€§åˆ†æç•¶å‰è¨­è¨ˆçš„è«–æ–‡      | ğŸ”´ åš´é‡ä¸è¶³                    | **æš—é»‘æ¨¡å¼æ–‡ç»ç¼ºå¤±**       |
| 4. é«˜å±¤åŸå‰‡       | WHO, NIST ç­‰æ¡†æ¶              | ğŸ”´ ç¼ºå¤±                        | ç°è‰²æ–‡ç»å°šæœªä¸‹è¼‰           |
| 5. ç•Œé¢å±¤å¯¦ç¾     | å…·é«”è¨­è¨ˆæ¨¡å¼/ç•Œé¢æ¡ˆä¾‹         | ğŸŸ¡ ä¸­ç­‰                        | éœ€è¦æ›´å¤šè¨­è¨ˆæ¨¡å¼æ–‡ç»       |

---

# å…­ã€èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥

## 6.1 æ ¸å¿ƒåŸå‰‡èª¿æ•´

| ç•¶å‰ç­–ç•¥             | å•é¡Œ                       | æ”¹é€²ç­–ç•¥                       |
| -------------------- | -------------------------- | ------------------------------ |
| æ‰€æœ‰æ¢ä»¶ç”¨ AND é€£æ¥  | äº¤é›†éå°                   | **åˆ†å±¤æœç´¢**ï¼šå…ˆå¯¬å¾Œçª„         |
| ä¸€æ¬¡æœç´¢åŒ…å«æ‰€æœ‰æ¦‚å¿µ | éŒ¯ééƒ¨åˆ†åŒ¹é…è«–æ–‡           | **å¤šæ¬¡ç°¡åŒ–æœç´¢** â†’ åˆä½µçµæœ    |
| åŒæ™‚è¦æ±‚å¤šå€‹é ˜åŸŸè¡“èª | è·¨å­¸ç§‘è«–æ–‡å¯èƒ½åªç”¨ä¸€ç¨®è¡“èª | **OR æ“´å±•åŒç¾©è©** + è¼ƒå°‘çš„ AND |

## 6.2 ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰â€” èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥

### ç¬¬ä¸€å±¤ï¼šå¯¬æ³›æ¢ç´¢

**Web of Science / Scopus**

```
æœç´¢ 1Aï¼š
TS=(("older adult*" OR "elderly" OR "senior*" OR "aging" OR "ageing")
AND ("conversational agent*" OR "voice assistant*" OR "chatbot*" 
OR "virtual assistant*" OR "dialogue system*"))

æ™‚é–“ï¼š2018-2026
é æœŸçµæœï¼š200-500 ç¯‡
è¡Œå‹•ï¼šç¯©é¸æ¨™é¡Œï¼Œä¿ç•™èˆ‡å¥åº·æˆ– HCI ç›¸é—œçš„ 50-100 ç¯‡
```

**ç‚ºä»€éº¼é€™æ¨£èª¿æ•´**ï¼šç§»é™¤ "health*" AND "HCI" çš„å¼·åˆ¶è¦æ±‚ï¼Œç¬¬ä¸€å±¤ä¸éåº¦é™åˆ¶ï¼Œå¾ŒçºŒæ‰‹å‹•ç¯©é¸ã€‚

### ç¬¬äºŒå±¤ï¼šä¸­ç­‰èšç„¦

```
æœç´¢ 1Bï¼š
TS=(("older adult*" OR "elderly" OR "senior*")
AND ("conversational agent*" OR "voice assistant*" OR "chatbot*")
AND ("health*" OR "healthcare" OR "wellbeing" OR "medical"))

WoS åˆ†é¡é™åˆ¶ï¼šComputer Science, Health Care Sciences, Gerontology
é æœŸçµæœï¼š100-200 ç¯‡
```

### ç¬¬ä¸‰å±¤ï¼šç²¾ç¢ºå®šä½

**ACM Digital Library**

```
æœç´¢ 1Cï¼š
æœƒè­°é™åˆ¶ï¼šCHI, CSCW, ASSETS, DIS, UIST
é—œéµè©ï¼š("older adult*" OR elderly) AND (conversational OR voice OR chatbot)
æ™‚é–“ï¼š2018-2026
é æœŸçµæœï¼š30-80 ç¯‡
```

**ç‚ºä»€éº¼é€™æ¨£èª¿æ•´**ï¼šç›´æ¥åœ¨é ‚æœƒæœç´¢ï¼Œä¸éœ€è¦é¡å¤– "HCI" é—œéµè©ï¼ˆé€™äº›æœƒè­°æœ¬èº«å°±æ˜¯ HCIï¼‰ã€‚

---

## 6.3 ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸± â€” èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥ï¼ˆæ›´æ–°ï¼šæ ¸å¿ƒæ–‡ç»å·²å®Œæˆï¼Œè£œå……æœç´¢ç­–ç•¥ï¼‰

### âœ… å·²å®Œæˆçš„æ ¸å¿ƒæ–‡ç»å®šä½

**æˆåŠŸç­–ç•¥ç¸½çµ**ï¼š

- âœ… **Gray et al. (2018)**ï¼šå·²é€šé ACM Digital Library åŸ·è¡Œä½œè€…åæœç´¢ï¼Œä¸‹è¼‰ PDF ä¸¦å°å…¥ Zoteroï¼Œå·²è©•ä¼°ç‚º Tier 1
- âœ… **Susser et al. (2019)**ï¼šå·²é€šéç›´æ¥è¨ªå• Internet Policy Review ç¶²ç«™ä¸‹è¼‰ PDF ä¸¦å°å…¥ Zoteroï¼Œå·²è©•ä¼°ç‚º Tier 1
- âœ… **Brignull (2023/2024)**ï¼šå·²ç¢ºèªç‚ºæ›¸ç±ï¼ˆTestimonium Ltdï¼‰ï¼Œå·²ä»¥ epub æ ¼å¼æ”¶éŒ„ä¸¦å°å…¥ Zoteroï¼Œå·²è©•ä¼°ç‚º Tier 1

### è£œå……æœç´¢ç­–ç•¥ï¼ˆé”åˆ° 80-100% è¦†è“‹ç‡ï¼‰

ç‚ºé”åˆ° 5-8 ç¯‡ç›®æ¨™ï¼Œéœ€è¦è£œå…… 1-2 ç¯‡æ–‡ç»ï¼š

- **Gull (2025)**ï¼šæª¢æŸ¥é€šé McGill åœ–æ›¸é¤¨ç¢ºèªé›»å­æ›¸è¨ªå•æ¬Šé™
- **FAccT æœƒè­°è«–æ–‡**ï¼šæœç´¢ ACM FAccT æœƒè­°ä¸­é—œæ–¼å…¬å¹³æ€§ã€é€æ˜åº¦ã€æ“ç¸±çš„è«–æ–‡
- **å…¶ä»–æš—é»‘æ¨¡å¼ç ”ç©¶**ï¼šæœç´¢ CHIã€DIS ç­‰ HCI æœƒè­°çš„æœ€æ–°è«–æ–‡

### ç¬¬ä¸€å±¤ï¼šå»ºç«‹æš—é»‘æ¨¡å¼åŸºç¤æ–‡ç»åº«ï¼ˆè£œå……æœç´¢ï¼‰

**ACM Digital Libraryï¼ˆå¿…é ˆä½¿ç”¨ï¼‰**

```
æœç´¢ 2Bï¼š
[Title or Abstract]: "dark pattern*" OR "deceptive pattern*" OR "deceptive design"
æ™‚é–“ï¼š2010-2026
é æœŸçµæœï¼š50-150 ç¯‡
è¡Œå‹•ï¼šæ¨™è¨˜æ‰€æœ‰ CHI/CSCW/DIS è«–æ–‡ï¼Œè£œå…… Gray et al. 2018 ä¹‹å¤–çš„æ–‡ç»
```

**ç‚ºä»€éº¼é€™æ¨£èª¿æ•´**ï¼šç§»é™¤ AI, ethics, user interface çš„å¼·åˆ¶è¦æ±‚ï¼Œå…ˆå»ºç«‹å®Œæ•´æ–‡ç»åŸºç¤ã€‚æ ¸å¿ƒæ–‡ç»ï¼ˆGray, Susser, Brignullï¼‰å·²å®Œæˆï¼Œæ­¤æœç´¢ç”¨æ–¼è£œå……å…¶ä»–ç›¸é—œæ–‡ç»ã€‚

```
æœç´¢ 2Bï¼ˆæ“´å±•è¡“èªï¼‰ï¼š
[Title or Abstract]: "manipulative design" OR "coercive design" 
                     OR "deceptive interface*" OR "antipattern*"
é æœŸçµæœï¼š20-50 ç¯‡
```

### ç¬¬äºŒå±¤ï¼šæ“ç¸±å€«ç†ç†è«–æ–‡ç»

**Google Scholar**

```
æœç´¢ 2Cï¼š
"Daniel Susser" "manipulation" "technology"
OR
"persuasive technology" "ethics" "dark"
é æœŸï¼šæ‰¾åˆ° Susser et al. 2019
```

**Web of Science / Scopus**

```
æœç´¢ 2Dï¼š
TS=(("persuasive technolog*" OR "captology" OR "behavior* change")
AND ("ethics" OR "manipulation" OR "autonomy" OR "nudg*"))
å­¸ç§‘é™åˆ¶ï¼šComputer Science, Ethics, Communication
é æœŸçµæœï¼š100-200 ç¯‡
```

### ç¬¬ä¸‰å±¤ï¼šèˆ‡å¥åº·é ˜åŸŸé€£çµ

```
æœç´¢ 2Eï¼š
("dark pattern*" OR "deceptive design")
AND ("health*" OR "medical" OR "clinical" OR "patient")
é æœŸçµæœï¼š5-20 ç¯‡
```

### ç¬¬å››å±¤ï¼šFAccT æœƒè­°å°ˆé …

```
æœç´¢ 2Fï¼š
æœƒè­°é™åˆ¶ï¼šFAccT æˆ– FAT*
é—œéµè©ï¼šmanipulation OR autonomy OR consent OR transparency
æ™‚é–“ï¼š2018-2026
é æœŸçµæœï¼š20-50 ç¯‡
```

---

## 6.4 ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº â€” èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥

### æ”¹é€²é»ï¼šåˆ†é›¢å·¥å…·é¡å‹å’Œç ”ç©¶ç„¦é»

```
æœç´¢ 3Aï¼ˆæ•¸å­—å¥åº·å·¥å…·ï¼‰ï¼š
TS=(("older adult*" OR "elderly")
AND ("digital health" OR "eHealth" OR "mHealth" OR "patient portal*"))
å­¸ç§‘é™åˆ¶ï¼šMedical Informatics, Gerontology
é æœŸçµæœï¼š300-600 ç¯‡
```

```
æœç´¢ 3Bï¼ˆèšç„¦èŠå¤©æ©Ÿå™¨äººï¼‰ï¼š
TS=(("older adult*" OR "elderly")
AND ("chatbot*" OR "conversational agent*" OR "virtual health assistant*")
AND ("health*" OR "medical"))
é æœŸçµæœï¼š50-100 ç¯‡
```

```
æœç´¢ 3Cï¼ˆæ¡†æ¶å°å‘ï¼‰ï¼š
"MOLD-US" OR "Wildenbos"
OR
"halo effect" AND "privacy" AND ("health*" OR "medical")
é æœŸï¼šæ‰¾åˆ° Wildenbos et al. 2018 å’Œ Ellis et al. 2025
```

---

## 6.5 ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI â€” èª¿æ•´å¾Œçš„æœç´¢ç­–ç•¥

### å­¸è¡“æ–‡ç»æœç´¢

```
æœç´¢ 4Aï¼ˆAI å€«ç†æ¡†æ¶ï¼‰ï¼š
TS=(("AI ethics" OR "AI governance" OR "responsible AI" OR "trustworthy AI")
AND ("framework" OR "guideline*" OR "principle*"))
å­¸ç§‘ï¼šComputer Science, Ethics
é æœŸçµæœï¼š200-400 ç¯‡
```

```
æœç´¢ 4Bï¼ˆå¯è§£é‡‹æ€§èˆ‡é€æ˜åº¦ï¼‰ï¼š
TS=(("explainable AI" OR "XAI" OR "AI transparency")
AND ("health*" OR "medical")
AND ("usability" OR "user" OR "design"))
é æœŸçµæœï¼š100-200 ç¯‡
```

### ç°è‰²æ–‡ç»ç²å–

| æ–‡ç»               | ä¸‹è¼‰é€£çµ                                                              | å‚™è¨»                     |
| ------------------ | --------------------------------------------------------------------- | ------------------------ |
| WHO (2021)         | https://www.who.int/publications/i/item/9789240029200                 | âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero    |
| NIST AI RMF (2023) | https://nvlpubs.nist.gov/nistpubs/ai/NIST.AI.100-1.pdf                | âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero    |
| CIFAR (2023)       | https://cifar.ca/wp-content/uploads/2023/11/aican-impact-2023-eng.pdf | âœ… å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero    |
| Amii               | https://www.amii.ca/responsible-ai/                                   | â³ å¾…ä¸‹è¼‰ï¼ˆå¯èƒ½éœ€è¦è¨»å†Šï¼‰ |

---

## 6.6 è·¨ä¸»é¡Œæ•´åˆç­–ç•¥

### ä¸è¦ç”¨ä¸€å€‹æœç´¢å­—ä¸²æ•´åˆæ‰€æœ‰ä¸»é¡Œ

**æ”¹é€²ç­–ç•¥**ï¼š

1. **å…ˆåˆ†åˆ¥å»ºç«‹å„ä¸»é¡Œæ–‡ç»åº«**
   - ä¸»é¡Œä¸€ â†’ 50 ç¯‡
   - ä¸»é¡ŒäºŒ â†’ 30 ç¯‡
   - ä¸»é¡Œä¸‰ â†’ 60 ç¯‡
   - ä¸»é¡Œå›› â†’ 40 ç¯‡
   - **ç¸½è¨ˆï¼š~180 ç¯‡å€™é¸è«–æ–‡**

2. **é€šé Zotero æ¨™ç±¤è­˜åˆ¥äº¤å‰è«–æ–‡**
   ```
   Zotero é«˜ç´šæœç´¢ï¼š
   æ¨™ç±¤åŒ…å« #Topic1 AND #Topic2 â†’ è­˜åˆ¥è·¨ä¸»é¡Œè«–æ–‡
   ```

3. **æœ‰é‡å°æ€§çš„å°ç¯„åœæ•´åˆæœç´¢**
   ```
   æ•´åˆæœç´¢ Iï¼ˆè€å¹´äºº + éš±ç§ + AIï¼‰ï¼š
   TS=(("older adult*" OR "elderly")
   AND ("privacy" OR "consent")
   AND ("AI" OR "artificial intelligence")
   AND ("health*"))
   é æœŸï¼š10-30 ç¯‡
   ```

---

# ä¸ƒã€è¡Œå‹•è¨ˆåŠƒèˆ‡æ™‚é–“è¡¨

## 7.1 Week 2 æœ«ï¼ˆå‰©é¤˜ 1-2 å¤©ï¼‰

| å„ªå…ˆç´š  | ä»»å‹™                                | æ™‚é–“       | ç›®æ¨™                                                            |
| ------- | ----------------------------------- | ---------- | --------------------------------------------------------------- |
| ğŸ”´ **1** | å®šä½å’Œä¸‹è¼‰è¨ˆåŠƒæ›¸ä¸­å·²åˆ—å‡ºçš„æ ¸å¿ƒæ–‡ç»  | 1-1.5 å°æ™‚ | å®šä½ Gray et al. 2018, Susser et al. 2019, Brignull 2024 ä¸¦ä¸‹è¼‰ |
| ğŸŸ  **2** | å®Œæˆå·²æ”¶é›†è«–æ–‡çš„è©•ä¼°å’Œåˆ†é¡          | 2 å°æ™‚     | ç¢ºèª Tier ç­‰ç´šï¼Œæ›´æ–° Zotero æ¨™ç±¤                                |
| ğŸŸ  **3** | åŸ·è¡Œæœç´¢ 2B, 2Cï¼ˆæš—é»‘æ¨¡å¼è£œå……æœç´¢ï¼‰ | 1 å°æ™‚     | æ“´å±•æš—é»‘æ¨¡å¼æ–‡ç»åº«                                              |
| ğŸŸ¡ **4** | åŸ·è¡Œæœç´¢ 1Dï¼ˆä½œè€…è¿½è¹¤ï¼‰             | 45 åˆ†é˜    | è£œå…… Brewer çš„å…¶ä»–è«–æ–‡                                          |
| ğŸŸ¡ **5** | è£œå……æœç´¢è¨˜éŒ„æ–‡æª”                    | 1 å°æ™‚     | å›æº¯è¨˜éŒ„ç¬¬ä¸€è¼ªå’Œç¬¬äºŒè¼ªæœç´¢                                      |

## 7.2 Week 3 åˆï¼ˆ2-3 å¤©ï¼‰

### 7.2.1 å¾…è©•ä¼°æ–‡ç»çš„è™•ç†è¨ˆåŠƒ

**å¾…è©•ä¼°æ–‡ç»æ¸…å–®ï¼ˆ3ç¯‡ï¼‰**ï¼š
1. **Huang et al. (2025)** - "Designing Conversational AI for Aging: A Systematic Review" - CHI 2025
   - ç‹€æ…‹ï¼šâœ… å·²æ”¶é›†ï¼Œâ³ å¾…è©•ä¼°
   - è©•ä¼°æ¨™æº–ï¼šä½¿ç”¨ Round 2 è©•ä¼°æ¨™æº–ï¼ˆä¸‰ç¶­åº¦è¦†è“‹åˆ†æï¼‰
   - è©•ä¼°æ™‚é–“ï¼šWeek 3 åˆï¼ˆå„ªå…ˆç´šï¼šé«˜ï¼‰
   - é æœŸçµæœï¼šå¯èƒ½ç‚º Tier 1 æˆ– Tier 2ï¼ˆç³»çµ±æ€§å›é¡§ï¼Œéœ€æª¢æŸ¥æ˜¯å¦æ¶µè“‹ä¸‰ç¶­åº¦ï¼‰

2. **Gull (2025)** - "ä»£ç†è¨­è¨ˆæ¨¡å¼" - Springer
   - ç‹€æ…‹ï¼šâ³ å¾…ç²å–ï¼Œâ³ å¾…è©•ä¼°
   - ç²å–è¨ˆåŠƒï¼šé€šé McGill åœ–æ›¸é¤¨ç¢ºèªé›»å­æ›¸è¨ªå•æ¬Šé™ï¼ˆWeek 3 åˆï¼‰
   - è©•ä¼°æ¨™æº–ï¼šä½¿ç”¨ Round 2 è©•ä¼°æ¨™æº–ï¼ˆä¸‰ç¶­åº¦è¦†è“‹åˆ†æï¼‰
   - è©•ä¼°æ™‚é–“ï¼šç²å–å¾Œç«‹å³è©•ä¼°

3. **FAccT æœƒè­°è«–æ–‡**ï¼ˆå¾…æœç´¢ï¼‰
   - ç‹€æ…‹ï¼šâŒ å¾…æœç´¢ï¼Œâ³ å¾…è©•ä¼°
   - æœç´¢è¨ˆåŠƒï¼šåŸ·è¡Œ FAccT æœƒè­°è«–æ–‡è£œå……æœç´¢ï¼Œç›®æ¨™æ‰¾åˆ° 1-2 ç¯‡ç›¸é—œæ–‡ç»ï¼ˆWeek 3 åˆï¼‰
   - è©•ä¼°æ¨™æº–ï¼šä½¿ç”¨ Round 2 è©•ä¼°æ¨™æº–ï¼ˆä¸‰ç¶­åº¦è¦†è“‹åˆ†æï¼‰
   - è©•ä¼°æ™‚é–“ï¼šæœç´¢å¾Œç«‹å³è©•ä¼°

**è©•ä¼°æ¨™æº–ï¼ˆèˆ‡ Round 2 ä¸€è‡´ï¼‰**ï¼š
- **Tier 1**ï¼šä¸‰ç¶­åº¦è¦†è“‹ï¼ˆharm/access/usability, trust/legitimacy/support/expectation/privacy/relational, design/interaction/analysis/transparencyï¼‰
- **Tier 2**ï¼šéƒ¨åˆ†è¦†è“‹ï¼ˆ2 å€‹ç¶­åº¦æˆ– 1 å€‹ç¶­åº¦æ·±åº¦è¦†è“‹ï¼‰
- **Tier 3**ï¼šå–®ä¸€ç¶­åº¦è¦†è“‹
- **Unaccepted**ï¼šæœªé€£çµç•Œé¢è¨­è¨ˆæˆ–ä¸‰ç¶­åº¦åˆ†ææ¡†æ¶

**è™•ç†æ™‚é–“è¡¨**ï¼š
- Week 3 åˆï¼ˆç¬¬ 1-2 å¤©ï¼‰ï¼šå®Œæˆ Huang (2025) è©•ä¼°ï¼Œç²å–ä¸¦è©•ä¼° Gull (2025)
- Week 3 åˆï¼ˆç¬¬ 2-3 å¤©ï¼‰ï¼šåŸ·è¡Œ FAccT æœç´¢ä¸¦è©•ä¼°çµæœ
- Week 3 ä¸­ï¼šæ ¹æ“šè©•ä¼°çµæœèª¿æ•´å„ä¸»é¡Œçš„è£œå……æœç´¢è¨ˆåŠƒ

**å¦‚æœè©•ä¼°çµæœç‚º Unaccepted çš„æ›¿ä»£æ–¹æ¡ˆ**ï¼š
- ä¸»é¡Œä¸€ï¼šå¦‚æœ Huang (2025) ç‚º Unacceptedï¼Œéœ€è£œå……æœç´¢ CHI 2025 å…¶ä»–ç›¸é—œè«–æ–‡
- ä¸»é¡ŒäºŒï¼šå¦‚æœ Gull (2025) æˆ– FAccT è«–æ–‡ç‚º Unacceptedï¼Œéœ€åŸ·è¡Œé¡å¤–æœç´¢ï¼ˆè¦‹ä¸»é¡ŒäºŒè£œå……ç­–ç•¥ï¼‰

### 7.2.2 Week 3 åˆä»»å‹™å„ªå…ˆç´šï¼ˆæ›´æ–°ï¼‰

| å„ªå…ˆç´š  | ä»»å‹™                                   | æ™‚é–“     | ç›®æ¨™                           |
| ------- | -------------------------------------- | -------- | ------------------------------ |
| ğŸ”´ **1** | å®Œæˆå¾…è©•ä¼°æ–‡ç»çš„åˆ†é¡ï¼ˆHuang 2025ï¼‰     | 1 å°æ™‚   | ä½¿ç”¨ Round 2 è©•ä¼°æ¨™æº–å®Œæˆè©•ä¼°  |
| ğŸŸ  **2** | ç²å–ä¸¦è©•ä¼° Gull (2025)                 | 1.5 å°æ™‚ | é€šé McGill åœ–æ›¸é¤¨ç¢ºèªè¨ªå•æ¬Šé™ |
| ğŸŸ  **3** | åŸ·è¡Œæœç´¢ 2D, 2E, 2Fï¼ˆèªªæœæŠ€è¡“ã€FAccTï¼‰ | 2 å°æ™‚   | æ“´å±•æš—é»‘æ¨¡å¼æ–‡ç»åº«è‡³ 20-30 ç¯‡  |
| ğŸŸ¡ **4** | åŸ·è¡Œæœç´¢ 1Cï¼ˆé ‚æœƒæœç´¢ï¼‰                | 1.5 å°æ™‚ | ASSETS, CHI è£œå……æœç´¢           |
| ğŸŸ¡ **5** | åŸ·è¡Œæœç´¢ 3Dï¼ˆJMIR ç›´æ¥æœç´¢ï¼‰           | 1 å°æ™‚   | æœ€æ–°å¯¦è­‰ç ”ç©¶                   |
| ğŸŸ¢ **6** | åŸ·è¡Œæœç´¢ 4A, 4Bï¼ˆå­¸è¡“æ¡†æ¶ï¼‰            | 1.5 å°æ™‚ | è£œå……å­¸è¡“ AI å€«ç†æ–‡ç»           |

## 7.3 Week 3 ä¸­ï¼ˆå¼•æ–‡è¿½è¹¤æº–å‚™ï¼‰

| ä»»å‹™               | èªªæ˜                                               |
| ------------------ | -------------------------------------------------- |
| è¨­ç½®å¼•æ–‡è¿½è¹¤å·¥å…·   | Web of Science Citation Alert, Google Scholar è¿½è¹¤ |
| åˆæ­¥å¼•æ–‡ç¶²çµ¡å¯è¦–åŒ– | ä½¿ç”¨ Connected Papers ç‚ºæ ¸å¿ƒç¨®å­è«–æ–‡å‰µå»ºå¼•æ–‡åœ–     |
| ç¨®å­è«–æ–‡ç¢ºèª       | æ¯å€‹ä¸»é¡Œåˆ—å‡º 5-8 ç¯‡ç¢ºèªçš„ç¨®å­è«–æ–‡ï¼Œé™„é¸æ“‡ç†ç”±      |
| å°å¸«æœƒè­°æº–å‚™       | æ•´ç†ç¨®å­è«–æ–‡æ¸…å–®ã€æœç´¢ç­–ç•¥æ–‡æª”ã€é‡åˆ°çš„æŒ‘æˆ°         |

## 7.4 Week 2 æœ«æª¢æŸ¥æ¸…å–®ï¼ˆæ›´æ–°ï¼šRound 2 è©•ä¼°å¾Œï¼‰

- [x] **ä¸»é¡Œä¸€**ï¼šå®Œæˆå·²æ”¶é›† 8 ç¯‡è«–æ–‡çš„ Tier è©•ä¼°å’Œåˆ†é¡ âœ…
  - [x] ç¢ºèª 1 ç¯‡ Tier 1ï¼ˆBrewer CHI EAï¼‰
  - [x] ç¢ºèª 3 ç¯‡ Tier 2ï¼ˆZubatiy, An, Evenï¼‰
  - [x] ç¢ºèª 2 ç¯‡ Tier 3ï¼ˆBrewer TiiS, Duï¼‰
  - [x] æ¨™è¨˜ 1 ç¯‡ Unacceptedï¼ˆMartin-Hammondï¼‰
  - [ ] å®Œæˆ 1 ç¯‡å¾…è©•ä¼°ï¼ˆHuang 2025ï¼‰
- [x] **ä¸»é¡ŒäºŒ**ï¼šå®šä½å’Œä¸‹è¼‰æ ¸å¿ƒæ–‡ç» âœ… **å·²å®Œæˆ**
  - [x] Gray et al. (2018) â€” âœ… å·²å®šä½ä¸¦ä¸‹è¼‰ PDFï¼ŒZotero å·²æ›´æ–°ï¼Œâœ… **Tier 1**
  - [x] Susser et al. (2019) â€” âœ… å·²å®šä½ä¸¦ä¸‹è¼‰ PDFï¼ŒZotero å·²æ›´æ–°ï¼Œâœ… **Tier 1**
  - [x] Brignull (2023/2024) â€” âœ… å·²ç¢ºèªç‚ºæ›¸ç±ï¼ˆTestimonium Ltdï¼‰ï¼Œå·²ä»¥ epub æ ¼å¼æ”¶éŒ„ï¼ŒZotero å·²æ›´æ–°ï¼Œâœ… **Tier 1**
  - [x] å®Œæˆå·²æ”¶é›†æ–‡ç»çš„ Tier è©•ä¼°å’Œåˆ†é¡ âœ… **å·²å®Œæˆ**ï¼ˆå…¨éƒ¨è©•ç‚º Tier 1ï¼‰
- [x] **ä¸»é¡Œä¸‰**ï¼šå®Œæˆå·²æ”¶é›† 6 ç¯‡è«–æ–‡çš„ Tier è©•ä¼°å’Œåˆ†é¡ âœ…
  - [x] ç¢ºèª 1 ç¯‡ Tier 2ï¼ˆWildenbos 2018ï¼‰âœ…
  - [x] æ¨™è¨˜ 5 ç¯‡ Unacceptedï¼ˆEllis, Sakaguchi-Tang, Kidman, Ma, Turnerï¼‰
- [x] **ä¸»é¡Œå››**ï¼šå®Œæˆå·²æ”¶é›† 6 ç¯‡è«–æ–‡çš„ Tier è©•ä¼°å’Œåˆ†é¡ âœ…
  - [x] ç¢ºèª 2 ç¯‡ Tier 1ï¼ˆPeixoto, Bhattacharyaï¼‰
  - [x] ç¢ºèª 4 ç¯‡ç°è‰²æ–‡ç»å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zoteroï¼ˆNIST, WHO, CIFAR, Amiiï¼‰âœ…
- [x] æ›´æ–° Zotero æ¨™ç±¤å’Œåˆ†é¡ âœ…ï¼ˆRound 2 è©•ä¼°å®Œæˆï¼‰
- [ ] è£œå……æœç´¢è¨˜éŒ„æ–‡æª”
- [ ] æº–å‚™å°å¸«æœƒè­°ææ–™ï¼ˆå« Round 2 è©•ä¼°çµæœï¼‰

## 7.5 é æœŸæ”¹é€²æ•ˆæœ

| ä¸»é¡Œ     | ç•¶å‰è¦†è“‹ç‡ï¼ˆæ›´æ–°ï¼šä¸»é¡ŒäºŒå·²æ”¶é›†ï¼‰                     | æ”¹é€²å¾Œç›®æ¨™                               |
| -------- | ---------------------------------------------------- | ---------------------------------------- |
| ä¸»é¡Œä¸€   | ~100% (8ç¯‡ï¼Œå« 1 Tier 1, 3 Tier 2, 2 Tier 3)         | 100% (8ç¯‡ï¼Œæé«˜ Tier 1 æ¯”ä¾‹)             |
| ä¸»é¡ŒäºŒ   | ~60% (3ç¯‡æ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼°)       | **80%** â­ (5ç¯‡ï¼Œè£œå…… 2 ç¯‡æ–‡ç»)           |
| ä¸»é¡Œä¸‰   | ~15% (1ç¯‡å¾…è©•ä¼°ï¼Œ5ç¯‡ Unaccepted)                     | **80%** â­ (5-6ç¯‡ï¼Œéœ€é‡æ–°æœç´¢)            |
| ä¸»é¡Œå››   | ~80% (6ç¯‡ï¼Œå« 2 Tier 1, 4 ç°è‰²æ–‡ç»)                  | 90% (6-7ç¯‡)                              |
| **ç¸½é«”** | **~68%** (21ç¯‡å·²æ”¶é›†ï¼Œ9ç¯‡ Tier 1-3ï¼Œå…¶ä¸­ 5ç¯‡ Tier 1) | **85%** (22-24ç¯‡ï¼Œæé«˜ Tier 1 è‡³ 40-50%) |

**Round 2 è©•ä¼°å¾Œçš„ç¾ç‹€ï¼ˆæ›´æ–°ï¼šä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å®Œæˆï¼‰**ï¼š
- âœ… å·²å®Œæˆ 21 ç¯‡æ–‡ç»çš„ç³»çµ±æ€§è©•ä¼°
- âœ… ç¢ºèª 11 ç¯‡ Tier 1-3 æ ¸å¿ƒæ–‡ç»ï¼ˆ6ç¯‡ Tier 1, 4ç¯‡ Tier 2, 1ç¯‡ Tier 3ï¼‰
- âœ… **ä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å®Œæˆ**ï¼š3 ç¯‡ï¼ˆGray 2018, Susser 2019, Brignull 2024ï¼‰ï¼Œå…¨éƒ¨è©•ç‚º Tier 1 âœ…
- âš ï¸ ä¸»é¡Œä¸‰éœ€é‡æ–°æœç´¢ï¼ˆ5ç¯‡ Unacceptedï¼Œåƒ… 1 ç¯‡ Tier 2ï¼‰

**å®Œæˆæ”¹é€²å¾Œç›®æ¨™**ï¼š
- ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰â€” ç¶­æŒ 8 ç¯‡ï¼Œæé«˜ Tier 1 æ¯”ä¾‹
- ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸± â€” è£œå…… 1-2 ç¯‡æ–‡ç»ï¼ˆæ ¸å¿ƒæ–‡ç»å·²å®Œæˆï¼‰
- ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº â€” é‡æ–°æœç´¢ç²å¾— 5-6 ç¯‡ç¬¦åˆä¸‰ç¶­åº¦æ¡†æ¶çš„æ–‡ç»
- ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI â€” ç¶­æŒ 4-5 ç¯‡

å®Œæˆé€™äº›æ”¹é€²å¾Œï¼Œæ‡‰è©²æ“æœ‰ç´„ **22-24 ç¯‡ç¢ºèªçš„ç¨®å­è«–æ–‡**ï¼ˆå« 8-10 ç¯‡ Tier 1ï¼‰ï¼Œå¯ä»¥åœ¨ Week 3 æœ«é–‹å§‹ç³»çµ±æ€§çš„å¼•æ–‡è¿½è¹¤ã€‚

---

# é™„éŒ„ï¼šæœç´¢å­—ä¸²èˆ‡å·¥å…·

## A.1 å®Œæ•´æœç´¢å­—ä¸²åƒè€ƒ

### ä¸»é¡Œä¸€ï¼šHCI èˆ‡å°è©±ä»£ç†/æ™ºèƒ½ç³»çµ±ï¼ˆè€å¹´äººï¼‰

**Web of Science / Scopus**

```
TS=((("older adult*" OR "elderly" OR "senior*" OR "aging" OR "ageing") 
AND ("conversational agent*" OR "voice assistant*" OR "intelligent system*" 
OR "chatbot*" OR "virtual assistant*" OR "smart speaker*" OR "dialogue system*") 
AND ("health*" OR "healthcare" OR "wellbeing" OR "independence" OR "aging in place"))
AND ("HCI" OR "human-computer interaction" OR "user experience" OR "UX" 
OR "interaction design" OR "usability"))
```

**IEEE Xplore**

```
("older adults" OR elderly OR seniors OR aging) 
AND ("conversational agents" OR "voice assistants" OR "intelligent systems" 
OR chatbots OR "virtual assistants") 
AND (health OR healthcare OR independence) 
AND (HCI OR "human-computer interaction" OR "user experience" OR usability)
```

**ACM Digital Library**

```
[Title or Abstract]: ("older adults" OR elderly OR seniors) 
AND ("conversational agents" OR "voice assistants" OR "intelligent systems") 
AND (health OR healthcare) 
AND (HCI OR "user experience" OR "interaction design")
```

### ä¸»é¡ŒäºŒï¼šAI æš—é»‘æ¨¡å¼èˆ‡æ“ç¸±

**Web of Science / Scopus**

```
TS=(("dark pattern*" OR "deceptive design" OR "manipulative design" 
OR "persuasive technology" OR "nudge" OR "digital manipulation") 
AND ("user interface" OR "UI" OR "UX" OR "interaction design" 
OR "artificial intelligence" OR "AI" OR "machine learning"))
AND ("ethics" OR "user autonomy" OR "transparency" OR "consent" 
OR "privacy" OR "trust")
```

**ACM Digital Library**

```
[Title or Abstract]: ("dark patterns" OR "deceptive design" OR manipulation) 
AND (AI OR "user interface" OR "interaction design") 
AND (ethics OR autonomy OR transparency)
```

### ä¸»é¡Œä¸‰ï¼šæ•¸å­—å¥åº·ã€è€å¹´åŒ–ã€å¯ç”¨æ€§èˆ‡èŠå¤©æ©Ÿå™¨äºº

**Web of Science / Scopus**

```
TS=((("older adult*" OR "elderly" OR "senior*" OR "aging" OR "ageing") 
AND ("digital health" OR "mHealth" OR "mobile health" OR "eHealth" 
OR "patient portal*" OR "health app*" OR "healthcare chatbot*" 
OR "conversational health agent*"))
AND ("usability" OR "accessibility" OR "user experience" OR "UX" 
OR "adoption" OR "attrition" OR "engagement" OR "trust" OR "privacy"))
```

### ä¸»é¡Œå››ï¼šæ²»ç†ã€é¢¨éšªèˆ‡è² è²¬ä»» AI

**Web of Science / Scopus**

```
TS=(("AI governance" OR "AI ethics" OR "responsible AI" OR "trustworthy AI" 
OR "AI risk management" OR "AI accountability" OR "AI transparency") 
AND ("healthcare" OR "health" OR "medical" OR "clinical"))
AND ("framework" OR "guideline*" OR "policy" OR "regulation" 
OR "design principle*" OR "implementation")
```

---

## A.2 æ•¸æ“šåº«ç‰¹å®šæŠ€å·§

### Web of Science
- ä½¿ç”¨ Cited Reference Search é€²è¡Œå‘å¾Œè¿½è¹¤
- åˆ©ç”¨ Times Cited æ’åºæ‰¾é«˜å½±éŸ¿åŠ›è«–æ–‡
- ç¯©é¸å™¨ï¼šDocument Types (Article, Review), Research Areas (Computer Science, Health Care Sciences)

### Scopus
- ä½¿ç”¨ Analyze search results æŸ¥çœ‹ä¸»è¦ä½œè€…ã€æ©Ÿæ§‹ã€ä¾†æº
- Citation Tracker åŠŸèƒ½è¿½è¹¤å¼•æ–‡
- ç¯©é¸å™¨ï¼šSubject Area (Computer Science, Medicine), Document Type

### IEEE Xplore
- é™åˆ¶ Content Type: Conferences, Journals & Magazines
- é‡é»æœƒè­°ï¼šCHI, ASSETS, IEEE VR, EMBC

### ACM Digital Library
- ä½¿ç”¨ The ACM Guide to Computing Literature æ›´å…¨é¢æœç´¢
- ç¯©é¸ Publication Type: Research Article, Review Article
- é‡é»æœƒè­°ç³»åˆ—ï¼šCHI, CSCW, UIST, DIS, ASSETS, FAccT

---

## A.3 å¸ƒæ—é‹ç®—ç¬¦ä½¿ç”¨æç¤º

| é‹ç®—ç¬¦       | åŠŸèƒ½                         | ç¯„ä¾‹                                   |
| ------------ | ---------------------------- | -------------------------------------- |
| **AND**      | ç¸®å°ç¯„åœï¼ˆæ‰€æœ‰æ¢ä»¶å¿…é ˆæ»¿è¶³ï¼‰ | "older adults" AND "chatbot"           |
| **OR**       | æ“´å¤§ç¯„åœï¼ˆä»»ä¸€æ¢ä»¶æ»¿è¶³ï¼‰     | "elderly" OR "seniors"                 |
| **å¼•è™Ÿ " "** | ç²¾ç¢ºè©çµ„åŒ¹é…                 | "dark patterns"                        |
| **æ˜Ÿè™Ÿ \***  | è©æ ¹è®ŠåŒ–                     | design* = design, designs, designed    |
| **æ‹¬è™Ÿ ( )** | æ§åˆ¶é‹ç®—å„ªå…ˆé †åº             | ("older adults" OR elderly) AND health |

---

## A.4 æœç´¢è¨˜éŒ„æ¨¡æ¿

### æœç´¢è¨˜éŒ„è¡¨æ ¼

| æœç´¢ID | æ—¥æœŸ       | æ•¸æ“šåº« | ä¸»é¡Œ    | æœç´¢å­—ä¸²        | ç¯©é¸å™¨        | ç¸½çµæœ | ç›¸é—œçµæœ | ç´å…¥ | å‚™è¨»             |
| ------ | ---------- | ------ | ------- | --------------- | ------------- | ------ | -------- | ---- | ---------------- |
| S1A    | 2026-01-24 | WoS    | Topic 1 | (è¦‹ä¸Šæ–‡)        | 2018-2026, CS | 342    | 87       | 12   | æ‰‹å‹•ç¯©é¸æ¨™é¡Œ     |
| S2A    | 2026-01-24 | ACM DL | Topic 2 | "dark pattern*" | 2010-2026     | 78     | 45       | 8    | æ‰¾åˆ° Gray 2018 âœ“ |

### è©³ç´°æœç´¢è¨˜éŒ„æ¨¡æ¿ï¼ˆç”¨æ–¼å›æº¯å’Œæœªä¾†è¨˜éŒ„ï¼‰

**æœç´¢è¨˜éŒ„æ‡‰åŒ…å«ä»¥ä¸‹ä¿¡æ¯**ï¼š

1. **åŸºæœ¬ä¿¡æ¯**ï¼š
   - æœç´¢æ—¥æœŸå’Œæ™‚é–“
   - æ•¸æ“šåº«åç¨±å’Œç‰ˆæœ¬
   - æœç´¢ä¸»é¡Œï¼ˆä¸»é¡Œä¸€/äºŒ/ä¸‰/å››ï¼‰

2. **æœç´¢ç­–ç•¥**ï¼š
   - å®Œæ•´æœç´¢å­—ä¸²ï¼ˆåŒ…æ‹¬å¸ƒæ—é‹ç®—ç¬¦ã€å¼•è™Ÿã€æˆªæ–·ç¬¦ï¼‰
   - ä½¿ç”¨çš„ç¯©é¸å™¨ï¼ˆæ™‚é–“ç¯„åœã€æ–‡ç»é¡å‹ã€å­¸ç§‘é ˜åŸŸã€èªè¨€ç­‰ï¼‰
   - æœç´¢å­—æ®µï¼ˆæ¨™é¡Œã€æ‘˜è¦ã€å…¨æ–‡ç­‰ï¼‰

3. **çµæœè™•ç†**ï¼š
   - ç¸½çµæœæ•¸é‡
   - åˆæ­¥ç¯©é¸æ±ºç­–ï¼ˆtitle/abstract screeningï¼‰å¾Œçš„ç›¸é—œçµæœæ•¸é‡
   - æœ€çµ‚ç´å…¥æ•¸é‡
   - æ’é™¤ç†ç”±ï¼ˆå¦‚é©ç”¨ï¼‰

4. **é—œéµç™¼ç¾**ï¼š
   - æ‰¾åˆ°çš„æ ¸å¿ƒæ–‡ç»ï¼ˆå¦‚ Gray 2018ï¼‰
   - æ„å¤–ç™¼ç¾çš„é‡è¦æ–‡ç»
   - æœç´¢ç­–ç•¥çš„æœ‰æ•ˆæ€§è©•ä¼°

5. **å¾ŒçºŒè¡Œå‹•**ï¼š
   - æ˜¯å¦éœ€è¦èª¿æ•´æœç´¢ç­–ç•¥
   - æ˜¯å¦éœ€è¦è£œå……æœç´¢

### ç¼ºå¤±è¨˜éŒ„çš„è£œæ•‘è¨ˆåŠƒ

**å·²æœ‰è¨˜éŒ„**ï¼š
- âœ… Round 1 æœç´¢ï¼šéƒ¨åˆ†è¨˜éŒ„ï¼ˆè¦‹å ±å‘Šç¬¬ 4.3 ç¯€ï¼‰
- âœ… ä½œè€…åæœç´¢ï¼šGray et al. (2018), Susser et al. (2019) çš„å®šä½éç¨‹å·²è¨˜éŒ„

**ç¼ºå¤±è¨˜éŒ„**ï¼ˆéœ€å›æº¯è£œå……ï¼‰ï¼š
- â³ Round 2 è£œå……æœç´¢çš„è©³ç´°éç¨‹
- â³ Brignull (2024) çš„å®šä½å’Œç²å–éç¨‹
- â³ ç°è‰²æ–‡ç»ï¼ˆNIST, WHO, CIFAR, Amiiï¼‰çš„ä¸‹è¼‰éç¨‹
- â³ Wildenbos (2018) çš„è©•ä¼°éç¨‹

**è£œæ•‘æ™‚é–“è¡¨**ï¼š
- Week 3 åˆï¼šå›æº¯è¨˜éŒ„ Round 2 æœç´¢éç¨‹
- Week 3 ä¸­ï¼šè£œå……ç°è‰²æ–‡ç»ç²å–è¨˜éŒ„
- æœªä¾†æœç´¢ï¼šå³æ™‚è¨˜éŒ„ï¼Œä½¿ç”¨ä¸Šè¿°æ¨¡æ¿

---

## A.5 Zotero æ¨™ç±¤ç³»çµ±å»ºè­°

```
ä¸»é¡Œæ¨™ç±¤ï¼š
#Topic1_HCI_Older_Adults_ConvAI
#Topic2_DarkPatterns_Manipulation
#Topic3_Digital_Health_Usability
#Topic4_AI_Governance_Ethics

äº¤å‰æ¨™ç±¤ï¼š
#Cross_Privacy
#Cross_Trust
#Cross_Transparency
#Cross_Autonomy

æ–¹æ³•æ¨™ç±¤ï¼š
#Method_Empirical
#Method_Review
#Method_Framework
#Method_PolicyGrey

ç‹€æ…‹æ¨™ç±¤ï¼š
#Seed_Confirmed
#Seed_Candidate
#Background_Only
#Citation_Tracing_Source
```

---

## A.6 è³ªé‡ç¯©é¸æ¨™æº–

### ç´å…¥æ¨™æº–
- ç™¼è¡¨åœ¨åŒè¡Œè©•å¯©æœŸåˆŠæˆ–é ‚ç´šæœƒè­°
- ç ”ç©¶æ–¹æ³•æ˜ç¢ºï¼ˆå¯¦è­‰ç ”ç©¶ã€ç³»çµ±æ€§ç¶œè¿°ã€æ¡†æ¶é–‹ç™¼ï¼‰
- èˆ‡ç ”ç©¶å•é¡Œç›´æ¥ç›¸é—œ
- æä¾›å¯ç”¨æ–¼å¼•æ–‡è¿½è¹¤çš„è±å¯Œåƒè€ƒæ–‡ç»

### æ’é™¤æ¨™æº–
- åƒ…æŠ€è¡“å¯¦ç¾ï¼ˆç„¡ HCI è¦–è§’ï¼‰
- éè‹±æ–‡æ–‡ç»ï¼ˆé™¤éç‰¹åˆ¥é‡è¦ï¼‰
- æœƒè­°æ‘˜è¦ï¼ˆå„ªå…ˆé¸æ“‡å®Œæ•´è«–æ–‡ï¼‰
- éæ–¼å¯¬æ³›æˆ–èˆ‡ä¸»é¡Œç„¡é—œ

---

**æ–‡ä»¶æ›´æ–°æ—¥æœŸ**ï¼š2026-01-24ï¼ˆå·²æ›´æ–° Round 2 è©•ä¼°çµæœï¼ŒåŒ…æ‹¬ä¸»é¡ŒäºŒã€ä¸»é¡Œä¸‰ Wildenbos Tier 2 è©•ä¼°ã€ä¸»é¡Œå››æœ€æ–°é€²å±•ï¼‰

**Round 2 è©•ä¼°ç¸½çµ**ï¼š
- âœ… å®Œæˆ 21 ç¯‡æ–‡ç»çš„ç³»çµ±æ€§è©•ä¼°å’Œåˆ†é¡
- âœ… æ˜ç¢ºè­˜åˆ¥ 7 ç¯‡ Unaccepted æ–‡ç»åŠå…¶æ’é™¤ç†ç”±
- âœ… ç¢ºèª 6 ç¯‡ Tier 1 æ ¸å¿ƒæ–‡ç»ï¼ˆPeixoto, Bhattacharya, Brewer CHI EA, Gray, Susser, Brignullï¼‰
- âœ… ç¢ºèª 4 ç¯‡ Tier 2 æ–‡ç»ï¼ˆAn, Zubatiy, Even, Wildenbosï¼‰âœ…
- âœ… **ä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨æ”¶é›†ä¸¦å®Œæˆ Tier 1 è©•ä¼°**ï¼šGray et al. (2018)ã€Susser et al. (2019) å’Œ Brignull (2023/2024) å·²æˆåŠŸå®šä½ã€ä¸‹è¼‰ä¸¦è©•ç‚º Tier 1
- âœ… **ä¸»é¡Œä¸‰é€²å±•**ï¼šWildenbos et al. (2018) å·²å®Œæˆ Tier 2 è©•ä¼°ï¼ŒMOLD-US æ¡†æ¶æä¾›çµæ§‹åŒ–æ–¹æ³•è­˜åˆ¥è€å¹´å¯ç”¨æ€§éšœç¤™
- âœ… **ä¸»é¡Œå››ç°è‰²æ–‡ç»æ›´æ–°**ï¼šCIFAR (2023) å·²ä¸‹è¼‰ä¸¦åŠ å…¥ Zotero
- âš ï¸ ä¸»é¡Œä¸‰ä»éœ€è£œå……æ›´å¤šç¬¦åˆç ”ç©¶å•é¡Œçš„æ–‡ç»
- âœ… **é‡è¦é€²å±•**ï¼šTier 1 æ–‡ç»æ¯”ä¾‹ç‚º 29%ï¼ŒTier 2 æ–‡ç»æ¯”ä¾‹ç‚º 19%
- âš ï¸ Tier 1 æ–‡ç»æ¯”ä¾‹ä»éœ€æå‡è‡³ 40-50%

**ä¸‹ä¸€æ­¥ï¼ˆWeek 3 é–‹å§‹ï¼‰**ï¼š
1. âœ… **å·²å®Œæˆ**ï¼šä¸»é¡ŒäºŒæ ¸å¿ƒæ–‡ç»å·²å…¨éƒ¨ä¸‹è¼‰ä¸¦å®Œæˆ Tier 1 è©•ä¼°ï¼ˆGray 2018, Susser 2019, Brignull 2024ï¼‰
2. âœ… **å·²å®Œæˆ**ï¼šä¸»é¡Œå››ç°è‰²æ–‡ç»å·²ä¸‹è¼‰ï¼ˆNIST, WHO, CIFARï¼‰
2. âœ… **å·²å®Œæˆ**ï¼šå®Œæˆä¸»é¡ŒäºŒå·²æ”¶é›†æ–‡ç»çš„ Tier è©•ä¼°å’Œåˆ†é¡ï¼ˆå…¨éƒ¨è©•ç‚º Tier 1ï¼‰
4. é‡æ–°æœç´¢ä¸»é¡Œä¸‰ï¼Œå°‹æ‰¾ç›´æ¥é€£çµå°è©±å¼ AI ç•Œé¢è¨­è¨ˆçš„æ–‡ç»
5. è£œå…… Tier 1 æ–‡ç»ï¼Œæé«˜ä¸‰ç¶­åº¦è¦†è“‹æ¯”ä¾‹
6. é–‹å§‹æ·±åº¦é–±è®€ç¢ºèªçš„ç¨®å­è«–æ–‡ï¼Œä¸¦åŸ·è¡Œå¼•æ–‡è¿½è¹¤ï¼ˆbackward + forward chainingï¼‰
